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Using single virion fusion assay to study influenza virus entry 
 
Hung-Lun Hsu, Ph. D. 
Cornell University [2018] 
Understanding the mechanism of influenza virus entry is critical for effectively 
developing anti-viral drugs and vaccines. The entry of influenza virus is mediated by 
two proteins: hemagglutinin (HA) and neuraminidase (NA). During virus infection, 
HA first binds to sialic acid moieties on epithelial cell membranes, triggering 
engulfment of the virus into the cell via endocytosis. As the endosome matures during 
trafficking, the pH decreases in the micro-environment, which triggers the 
conformational change of HA that induces membrane fusion of the viral and 
endosomal membranes. Fusion allows the virus to release viral RNA into the cytosol 
of the cell. Single particle tracking (SPT) enables the study of viral binding and 
membrane fusion at the single-virion level to obtain high resolution measurements of 
each of these processes in vitro. SPT combines total internal reflection fluorescence 
(TIRF) microscopy with microfluidics and supported lipid bilayers, making it a very 
powerful tool for host-pathogen membrane fusion studies. 
One concern about influenza is that the virus can mutate quickly via three 
mechanisms (i.e. error-prone RNA replication, influenza reassortment, and influenza 
recombination). Influenza virus mutation mechanisms may cause the emergence of 
new strains, some of which may lead to serious flu pandemics in humans. 
Understanding the fusion fitness of influenza strains at the single-virion level is 
crucial for the development of anti-viral fusion drugs which block genome transfer. 
However, high risk live influenza pandemic strains can be infectious and lethal to 
humans, which makes them a challenge to study in the laboratory environment 
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without significant safety protocols in place. To study the influenza pandemic virus, 
using a pseudovirus is the most common surrogate system for studying virus entry. 
However, before this work, no studies directly compared the entry processes of 
pseudoviruses with their wildtype particles. Here I use SPT to compare the fusion 
kinetics of influenza native virus and its pseudovirus analog and show that these 
particles do recapitulate the native behavior well. I will then show how I use 
pseudoviruses to mimic influenza reassortment and shed light on how influenza 
reassortment can infect virus entry. Next, I report results on SPT studies of virus entry 
of influenza virus H10N8 (JX346), a virus of concern because, although there have 
been only 3 confirmed cases, it was transmitted directly from chicken to human in 
2014, with high lethality. Lastly, I will expand the SPT technique to study the 
inhibitory mechanism of an influenza antiviral drug, IFITM3. IFITM3 has been 
shown to be able to stop influenza virus entry at the fusion step, and lead to the failure 
of infection.  
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Literature Review 
1.1. Membrane enveloped virus 
Viruses are obligatory intracellular parasites, and they can be simply categorized 
based on whether it has a viral envelope covering its protein capsids [1]. An 
enveloped virus obtains its membrane from the plasma membrane of the infected cell 
or host during the process of leaving the host (called “budding”) [2]. Together with 
the viral membrane, viral glycoproteins also are assembled into the viral envelope. 
The viral envelope may help viruses avoid the host immune system, and protect the 
viral cargo (e.g. RNA, polymerase). On the viral envelope membrane, there are 
glycoproteins that serve to identify and bind to the receptor sites on the host’s 
membrane [3]. Also, the viral glycoproteins also are responsible for releasing the 
virus genome into the host cells [4].  
Enveloped viruses include numerous pathogenic or lethal viruses, e.g. influenza virus 
(Orthomyxoviridae family) [5], Ebola virus (Filoviridae family) [6], severe acute 
respiratory syndrome (SARS) virus (Coronaviridae family) [7], human 
immunodeficiency virus (HIV) (Retroviridae) etc. However, not all enveloped viruses 
use the same pathway for entry. The major route of virus internalization is 
clathrin-mediated endocytosis, used by vesicular stomatitis virus (VSV) [8]. Another 
route is macropinocytosis, which is a non-selective uptake mechanism, used by Ebola 
virus [9-11] and human respiratory syncytial virus [12]. Some viruses, such as 
influenza virus,  can use both routes to be internalized [13-15].  
1.2. Influenza virus entry 
Influenza A viruses are enveloped, single-stranded, segmented, negative-sense 
RNA viruses that infect a wide variety of bird and mammalian species. Moreover, 
humans, swine, and birds are the biggest influenza virus reservoirs in the world [16]. 
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In order to target their host, influenza A viruses require hemagglutinin (HA). HA is a 
trimeric membrane-embedded glycoprotein that is a critical determinant of host 
tropism (e.g. humans, pigs, birds and horses), and mediates both binding to host cell 
surface sialic acid receptors and fusion of viral and host cell membranes [17-19]. 
Because of its crucial role in governing cell entry, tissue and host tropism, HA is also 
a key factor in regulating viral pathogenicity [20, 21]. On the other hand, influenza 
viruses require neuraminidase (NA) envelope glycoproteins for viral egress[22]. NA 
protein is a tetramer on the surface of virions and is responsible for catalyzing 
cleavage of terminal sialic acids [23, 24]. NA’s functional role is critical for the 
release of progeny viral particles from infected cells at late stages of the infection 
cycle [25], and prevents virus from binding to the mucus overlying the human airway 
epithelium [26]. Influenza A viruses are divided into subtypes based on antigenic and 
amino acid sequence differences of the HA and NA surface glycoproteins, composed 
of 18 and 11 known subtypes, respectively. While different HA and NA combinations 
are found in circulating influenza viruses, aquatic birds can be infected by most 
subtypes, while humans are known to be infected by three main subtypes: H1N1, 
H2N2, and H3N2 [27]. The human H2N2 subtype is not currently circulating, but was 
responsible for the 1957 pandemic [28]. The avian H5N1 and H9N2 subtypes have 
been recognized for their pandemic potential in the human population[29]. The 
transition of receptor usage from avian-like α2,3-linked to human-like α2,6-linked 
sialic acids represents a critical step for avian viruses to acquire efficient replication 
and transmission capabilities in humans[30]. Furthermore, understanding the effects 
of switching combinations of gene segments that occur during reassortment, in 
particular those encoding HA and NA, is critical for uncovering the basis of 
emergence of influenza viruses with increased pathogenicity and for pandemic 
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preparedness [31].  
During influenza virus entry, which occurs through the endocytic pathway, 
conformational changes of the HA are critical for virus fusion to occur [32]. HA is a 
type I transmembrane protein and represents a prototypical class I viral fusion protein 
that has been widely studied both structurally and functionally. HA is initially 
synthesized as an uncleaved precursor, HA0, which is proteolytically processed by 
host cell proteases into two subunits, HA1 and HA2, linked by two disulfide bonds. 
The HA1 subunit contains a globular domain with residues responsible for binding to 
sialic acids, while the core of the fusion machinery, the hydrophobic fusion peptide, is 
found within the membrane anchored HA2 subunit [20, 33]. The proteolytic cleavage 
event is critical for activating the HA, as it allows for exposure of the fusion peptide. 
In the late endosome, the pH drops from pH 6.5-6 to pH 5-4.5 causing the HA2 fusion 
domain to undergo major conformational changes. These changes expose the fusion 
peptide and enable it to be inserted into the target endosomal membrane. HA2 then 
refolds, and pulls viral and endosomal membranes together, allowing for hemifusion 
to occur and ultimately leading to the opening of the fusion pore and release of the 
viral genome [17, 34]. In previous studies, we and others have successfully applied a 
single-particle tracking (SPT) methodology combining total internal reflection 
microscopy (TIRFM), microfluidics, and supported lipid bilayers to study influenza 
HA-mediated fusion kinetics using native viruses or HA-pseudotyped viral particles 
[35-38]. 
1.3. Influenza risk assessment tool (IRAT) 
Influenza is the virus pathogen that causes flu, which causes 12,000 to 56,000 
deaths each year. In the 2017-2018 season, because the selection of strains used to 
make flu vaccines was incorrect, more than 6% of people that visited clinics and 
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emergency departments had an influenza-like illness [39]. This is the highest level of 
activity since the deadly H1N1 influenza pandemic, which caused the 284,000 deaths 
worldwide in 2009. Because correct prediction the flu vaccine each is critical in 
disease control and prevention, the Influenza Risk Assessment Tool (IRAT) was 
developed by the Centers of Disease Control and Prevention (CDC) to evaluate the 
pandemic potential of newly emerging influenza viruses or the viruses that currently 
circulate in animals. IRAT builds a framework which weights 10 risk elements and 
the top three weighted elements are human infection, transmission (laboratory animals) 
and receptor binding [40]. The other 7 elements include genomic variation, antiviral 
treatment susceptibility/resistance, existing population immunity, disease severity and 
pathogenesis, antigenic relationship to vaccine candidates, and global distribution 
(animals). The 10 risk elements are scored from 1 to 10, and each score is weighted 
according to importance of two scenarios: emergence and public health impact. The 
emergence scenario is the risk for the virus to achieve sustained human-to-human 
transmission, and the public health impact scenario is the risk for the virus to 
significantly impact public health if it were to achieve sustained human-to-human 
transmission.  
1.4. Acid sensitivity and stability 
Although the IRAT has already covered most of the important factors for 
evaluating the pandemic risk of influenza virus, there is evidence that besides virus 
receptor binding properties, virus fusion properties might also play a role in pandemic 
potential [41]. Russier and colleagues showed changes in the HA acid stability of the 
pandemic influenza virus (pH1N1) during its inter-species transmission from swine to 
humans. The HA activation pH decreased significantly when it transmitted from 
swine (activating pH > 5.5) to early human cases (pH 5.5), which further decreased in 
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human isolates characterized later in the pandemic (pH 5.4-5.2). Because the human 
airway tissue constitutes an acidic environment (pH 5.5-6.9), human influenza viruses 
have been shown to increase their acid stability to successfully infect host cells [42, 
43]. On the other hand, other than the obstacles that influenza viruses face in the 
macroenvironment, there are more issues during the endosomal escape process. 
During endosomal trafficking, HA requires acidification to trigger the conformational 
change of its fusion peptide to form a pore on the endosomal membrane to release 
viral RNA. However, the low pH environment might also deactivate HA, so 
endosomal escape fails. HA stability was defined as how long HA can maintain its 
fusogenicity while in an acidic environment by Costello et al. in 2015 [35]. 
Considering these scenarios, the acid sensitivity and acid stability might be worthy to 
be considered as features important for evaluating the risk of an influenza virus 
pandemic. 
1.5. Studying virus hemifusion at single-virion level. 
To better understand influenza virus entry and get virion-level information (HA 
acid stability and sensitivity), single-particle tracking (SPT) is an useful technique. 
Before SPT was invented and performed on studying virus-host entry kinetics, a 
similar but less sensitive technique, the bulk fusion assay was first reported in 1984. 
Hoekstra et al. utilized the self-dequenching fluorescence of a lipophilic fluorophore, 
octadecyl rhodamine B (R18) to detect the membrane fusion of biological membranes 
[44]. Bulk fusion then was used by Lowy et al. [45] and Loyter et al. [46] to 
investigate influenza viral membrane fusion and study the hemifusion kinetics with 
human erythrocyte membranes. Melikyan et al. further improved the bulk fusion 
technique by combining it with fluorescence microscopy, and they were able to 
observe the hemifusion and pore formation of retroviruses with 293T cell membranes 
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at the level of single particles [47]. The single-particle tracking technique finally 
became fully matured when Wessels et al and Floyd et al. used supported lipid 
bilayers to replace actual cell membranes, and utilized total internal reflection 
fluorescence (TIRF) microscopy to enhance the signal-to-noise ratio [37, 38]. In their 
study, they were able to quantify the hemifusion and pore formation kinetics from 
individual virions, and they further used an empirical equation, a cumulative gamma 
distribution equation, to fit the kinetics curves. The equation is shown below: 
𝑝! =  𝑘!!𝑡!!!𝛤(𝑁)!! 𝑒!!!! 𝑑𝑡 
With the fitting, they were able to extract two parameters from the kinetics, k and 
N, where kH is the hemifusion or pore formation rate constant, t is lag time, and N is 
an additional fit parameter, which they correlated to the number of steps or the 
number of HA trimers that must act concertedly to initiate fusion [37]. kH and N are 
usually plotted as a function of pH to study the dependence of hemifusion and pore 
formation on pH acidification that occurs in a maturing endosomal environment. 
Costello et al. further expanded the SPT technique to study virus-like particles [36], 
coronaviruses [48], and different influenza strains [35]. In my thesis, I will present my 
effort in expanding the SPT technique to study a surrogate virus system for 
pathogenic viruses, a pseudovirus system.  
1.6. Performing single-virion fusion assays on highly pathogenic virus. 
Pseudotyped particles, also called pseudovirions or pseudoviruses, are enveloped 
virus particles derived from a parental virus, typically a rhabdovirus (e.g. vesicular 
stomatitis virus, VSV) or a retrovirus (e.g. murine leukemia virus, MLV) that forms a 
viral core that can incorporate the envelope glycoprotein of a heterologous virus (e.g. 
influenza HA, or coronavirus spike) in its membrane [49-51]. Such viral particles 
acquire the host cell tropism, virus entry, and fusion characteristics governed by the 
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heterologous envelope glycoprotein used. As such, they constitute a powerful tool to 
study enveloped virus entry. Also, because they contain a replication-defective 
genome, they are safe surrogates of highly pathogenic enveloped viruses. 
Pseudotyped particles have been used for many applications, such as quantification of 
viral entry using reporter genes (e.g. luciferase or green fluorescent protein, GFP), 
investigation of the viral entry process of highly pathogenic viruses or viruses that 
cannot be cultured, and for controlling the host cell tropism of gene delivery vectors.  
For VSV pseudovirus production, Lawson et al. [52] and Whelan et al. [53] 
generated a recombinant virus in which the native fusion glycoprotein-encoding gene 
(G) is replaced by a GFP-encoding gene. Because they lack the essential 
glycoprotein-encoding gene, particles with such defective genome cannot undergo 
multiple rounds of infection [54]. This recombinant virus is used to infect mammalian 
cells expressing heterologous virus envelope glycoprotein such as HA by transfection. 
This results in the production of pseudotyped particles that bud from the plasma 
membrane. Such pseudotyped particles can then be used to infect target host cells for 
infectivity assays. The GFP gene contained in the pseudotyped particle genome is 
expressed in infected cells, allowing for easy readout of infectivity. Halbherr et al. 
used the VSV pseudotyping for studying influenza H5N1 and showed that the 
particles can be used for accurate detection of neutralizing antibodies against 
influenza viruses [55]. In the presence of neutralizing antibodies, influenza H5N1 
pseudoviruses were unable to infect cells.  
For MLV pseudovirus production, human embryonic kidney (HEK)-293T cells are 
co-transfected with a MLV gag-pol packing construct, a pTG-Luc transfer vector 
encoding a luciferase reporter, and a plasmid encoding the viral envelope glycoprotein 
of interest. The MLV structural proteins assemble and form pseudotyped particles 
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with the expressed envelope glycoprotein and containing the luciferase reporter gene. 
As such, luciferase activity in infected cells can be used as a measure of infectivity of 
the pseudotyped particles. (Fig. 1). The MLV pseudovirus production system (Fig. 1B)	
has been optimized and reported to be successful in producing and studying influenza 
H9N2 viruses [56]. Additionally, both pseudovirus systems described here can 
incorporate HA and NA from different strains. As such, they are ideal for studying 
influenza virus reassortment, as we can express specific combinations of HA and NA 
of interest. One useful application of the pseudovirus systems is that they allow us to 
study emerging influenza strains safely, which will be shown in this thesis. 
 
 
Figure 1. The cartoon shows the production of (A) VSV pseudoviruses and (B) MLV 
pseudoviruses. Both pseudoviral systems are designed so they can only undergo one 
infection cycle. Hence, the pseudoviruses are safer to use because they lack the ability 
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to replicate in the host cells.  
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CHAPTER 2 
Image restoration and analysis of influenza virions binding to membrane receptors 
reveal adhesion-strengthening kinetics 
Donald W. Lee, Hung-Lun Hsu, Kaitlyn B. Bacon, and Susan Daniel 
School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, New 
York, United States of America 
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Author Contributions 
SD conceived the project. S.D. and D.W.L. designed the experiments and wrote the 
manuscript. D.W.L. developed the algorithms and codes, performed final binding 
experiments, and analyzed the data. H.L.H. and K.B.B. measured the zeta potential of 
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2.1. Introduction 
Single-particle tracking (SPT) is a versatile technique for studying protein-protein 
binding interactions occurring at surfaces, particularly the binding of viruses to host 
cell membrane receptors [58-62]. Viral adhesion to host membranes is critical for 
viral infection, and dissecting this process is relevant for predicting virus emergence, 
determining susceptible hosts, or developing binding-inhibitory antiviral compounds. 
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SPT often deploys the use of imaging techniques such as total internal reflection 
fluorescence (TIRF) microscopy, which can track fluorescent virions within a 100-nm 
distance away from a surface (Fig 2a). The viral receptor can be loaded onto a flat 
substrate by tethering receptors to polymers attached covalently to the substrate [63], 
adsorbing lipid vesicles containing the receptor lipid or protein [64], or forming 
supported lipid bilayers (SLBs) containing membrane receptors [37, 61, 62, 65, 66]. 
The SLB option is advantageous because 1) the receptor type and surface density can 
be carefully controlled through bilayer preparation steps, 2) receptors are properly 
orientated in the membrane [67], 3) viral membrane fusion kinetics can be studied 
using the same assay [37, 38, 68-70], and 4) mobile lipids allow the virus to recruit 
receptors and form multivalent bonds. However, the SPT-SLB assay contains several 
technical challenges with experimental design, image processing, and binding kinetic 
data analysis that limit its adaptation as a standard analytical tool. To increase the 
utility of SPT-SLB assays, we explain the cause of and demonstrate solutions to these 
issues as we study of influenza virus binding to several types of α2,3 sialic acid (SA) 
glycolipids. 
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Figure 2.   SPT binding assay and receptor structures. a) Setup of SLB on TIRF 
microscope. Evanescent field illuminates regions where SLB and virus interacts. b) 
Structure of the sialic acid receptors for X-31 tested here. The α2,3-linked sialic acid 
groups are circled by the blue perimeters. Following the notation by Suzuki et al. [71], 
	
	
13	
	
sialic acid groups are labeled as either being in the internal (I) or terminal (T) 
position.  
 
One of the biggest barriers to using SPT for viral research is extracting particle 
information from images. Manually tracking particles is impractical, hence automated 
tracking software is needed and its proper performance is critical. Fluorescently 
labeled virions appear as white spots on a dark background, but often, dim particles 
exist that are only few pixels large and resemble bright shot noise. Dim particles are 
particularly detrimental to SPT binding studies because these are intermittently 
detected by the software and contribute many short, erroneous particle trajectories that 
skew the binding data. Increasing the particle fluorescence signal by using a more 
powerful excitation laser is not an effective solution to the problem because 
photobleaching destroys the signal before adequate data can be collected. 
Signal-to-noise ratios can be improved by developing better microscopy setups such 
as light sheet microscopy [72], using other dyes such as quantum dots [73, 74], or 
using dye-free strategies [75], but not all setups and samples can accommodate these 
improvement. Hence, developing image-processing techniques provides a means to 
benefit a broader range of studies with minimal changes to experimental procedures.   
Typical SPT image analysis software usually performs the following three steps: 
image restoration, particle detection, and particle trajectory linking. While much 
effort has been invested in improving particle detection [76-82] and particle linking 
algorithms [78, 82-88], less effort has been focused on developing image restoration 
algorithms for SPT application [89]. Particle tracking software generally 
underperforms when the signal-to-noise ratio (SNR) is below 4 [78]. Most SPT 
studies use image restoration techniques originally designed for standard photographs 
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and videos [90-93], which do not adequately restore dim particles with features barely 
larger than that of shot noise pixels. To resolve the intermittent particle tracking 
errors, we developed and provide a SPT image restoration algorithm called 
STAWASP (Segmented Temporal Averaging While Avoiding Synced Pixels). This 
algorithm effectively uses both spatial and temporal information from the video pixels 
to stabilize particle intensities, preserve particle features, and remove substantial noise 
from videos. 
Other challenges of SPT-SLB assays is customizing experiments for studying 
multivalent binding of viruses to receptor analogs, and interpreting the SPT 
binding/unbinding kinetic data. There are many experiment design choices to consider 
that affect the kinetic data, and we explain these choices in the context of designing 
experiments for studying influenza X-31 virus (H3N2 strain), which is a model for 
other enveloped viruses. Enveloped viruses are often labeled with membrane 
fluorophores since they do not interfere with protein functions and can be used in 
membrane fusion/dye-dequenching studies [36-38, 69, 70, 94]. Yet, quenched 
concentrations of membrane dye or inefficient labeling can generate substantial 
numbers of dim particles that are intermittently observable. Hence, tracking 
membrane-labeled X-31 virus serves as a useful test case for developing our image 
restoration algorithm and data analysis strategies.  
A typical influenza virion surface contains roughly 400-500 hemagglutinin (HA) 
proteins [95] that govern the multivalent binding of the virus to sialic acid receptors 
on host cells. In this work, we measured the binding times of influenza viruses to 
SLBs that separately contained glycolipids aGM1, GM1, GM3, or GD1a (Fig 1b). Except 
for aGM1, all glycolipids contain the α2,3 SA linkage but with different peripheral 
oligosaccharide structures. These structures serve to impart differences in binding 
	
	
15	
	
behavior that can be resolved when tracking stochastic binding events instead of 
ensemble-averaged binding events. We are also interested in counting the binding 
attempts made by viruses, which is not observable when using traditional binding 
assays that measure the change in collective adsorbed mass of viruses on a 
receptor-coated surface. 
Generally, viruses bind better to SA at the terminal position [71, 96, 97], but SPR 
studies have shown that X-31 virus does not bind to GM3 even though it also has a 
terminal SA [64]. Contrary to this study, X-31 virus can infect chicken red blood cells 
that have been incubated with GM3 receptors [98]. We show that the flu virus does 
bind weakly to GM3, observable with the experiment conditions and image restoration 
used in this work. Additionally, we show that binding residence time distributions 
reflect the adhesion-strengthening process via multivalent bonds that viruses use to 
stably bind to host membranes [99-102], and we present strategies to characterize 
these kinetics. 
 
2.2. Materials and Methods 
2.2.1. Producing lipid vesicles for SLBs 
Supported lipid bilayers (SLBs) containing glycolipids are made from lipid vesicles. 
To make the lipid vesicles, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
(POPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (POPG) 
[Avanti Polar Lipids, Alabaster, AL] were separately dissolved in chloroform, while 
glycolipids monosialotetrahexosylganglioside (GM1) [Avanti Polar Lipids, Alabaster, 
AL], monosialodihexosylganglioside (GM3), disialoganglioside (GD1a), and 
asialoganglioside (aGM1) [Sigma-Aldrich, St. Louis, MO] were separately dissolved in 
a 2:1 chloroform to methanol solution. Glycolipids and POPC solutions were mixed 
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together to yield 1 mol % of glycolipids, while POPG was added when necessary to 
maintain the same anionic charge density across all lipid samples (equivalent to 2 mol 
% of monovalent anionic lipids). Lipids were dried under vacuum for 3 hours and 
rehydrated in MES buffer (1 mM MES, 150 mM NaCl, pH 7) such that the final lipid 
concentration was 1 mg/mL. Lipids were extruded 10 times using a 1-directional, 
20-mL lipid extruder [Northern Lipids Inc., Burnaby, Canada] and a 50 nm pore-size 
polycarbonate membrane [GE Healthcare, Pittsburgh, PA] to yield 100 nm-diameter 
vesicles as determined by dynamic light scattering [Malvern Instruments, 
Worcestershire, UK]. Extruded lipids were collected in a new vial to ensure all lipids 
have passed the filter. 
2.2.2. Measuring surface charges of vesicles and viruses 
To ensure long-range electrostatic forces do not influence binding, the surface 
charges of the vesicles and lipid vesicles were measured using a zeta potential 
analyzer [Malvern Instruments, Worcestershire, UK]. Lipid vesicles at 0.25 mg/mL 
dilutions or X-31 virus (dye-labeled and unlabeled) at 0.008 mg/mL dilutions were 
added to zetacells (model DTS 1061) and subjected to light scattering measurements 
under an electric field. Triplicate measurements were performed at pH 7, 150 mM 
NaCl. 
2.2.3. Assembling the microfluidic device 
Virus binding experiments were performed inside a microfluidic device as shown 
elsewhere  [70]. Glass coverslip slides (No. 1.5 thickness) [VWR, Radner, PA] were 
cleaned for 10 min using a piranha solution composed of 30 vol % hydrogen peroxide 
solution (contains 50 wt % H2O2) [Sigma-Aldrich, St. Louis, MO] and 70 vol% 
concentrated sulfuric acid [VWR, Radner, PA]. Glass slides were stored in deionized 
water until use. A polydimethylsiloxane (PDMS) [Dow Corning, Midland, MI] mold 
	
	
17	
	
of microfluidic channels (135 µm wide, 75 µm high, and 1.5 cm long) was prepared 
on top of a patterned, hydrophobic silica wafer produced at the Cornell 
Nanofabrication Facility (CNF). An air-dried glass slide and the PDMS mold were 
annealed together after a 30-second oxygen plasma cleaning step at 700 µmHg 
oxygen pressure. Tygon tubes (0.02” ID x 0.06” OD) [Saint-Gobain Performance 
Plastic, Worcester, MA] were attached to the microfluidic device such that one end is 
submerged into the loading solution and the other end is attached to a syringe pump 
[Harvard Apparatus, Holliston, MA]. The microfluidic device was setup on an 
inverted total internal reflection fluorescence (TIRF) microscope with a 100x oil 
immersion objective and 1.46 numerical aperture [Carl Zeiss, Oberkochen, Germany. 
Model Axio Observer Z1]. A 561 nm laser was shined at a 70° incidence angle to 
generate an evanescent wave that illuminates the virus within ~100 nm from the 
glass-water interface. The camera in the microscope is a Hamamatsu ImageEM 
C9100-13 (Hamamatsu Photonics, Bridgewater, NJ). 
2.2.4. Forming SLBs inside microfluidic channels 
SLBs that act as host membrane mimics were formed by rupturing lipid vesicle on 
hydrophilic glass surfaces [9, 49]. Lipid vesicle solutions at 1 mg/mL vesicle 
concentration were loaded into the microfluidic channels at a flow rate of 100 µL/min 
for 1 min. Vesicles were incubated in the channels for 4 hours to form high quality, 
high-quality bilayers . Excess vesicles were rinsed away by flowing MES buffer at a 
flow rate of 100 µL/min for 3 min. 
2.2.5. Storing X-31 viruses until use 
X-31 (H3N2/Aichi/68) influenza virus was obtained from Charles River [Charles 
River Laboratories, North Franklin, CT] at a protein concentration of 2 mg/mL, which 
comes in a frozen state. The stock virus solution was defrosted, aliquoted into 5 µL 
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volumes and stored at -80°C until used. An aliquot of virus was freshly thawed and 
used for each experiment. While this procedure requires viruses to undergo  two 
thaw cycles that decreases viral infectivity relative to fresh virus, it is repeatable and 
out-competes the other option to store the virus liquid state until each use. The drop in 
infectivity for a 2nd thaw cycle has been reported to be from 108.6 to 107.0, whereas 
degradation over time at 0°C liquid state causes a larger drop in infectivity to 106.5 
[103]. The spherical morphology of virus was fairly well preserved after a 2nd thaw 
cycle, as confirmed in a separate EM study using the same virus batch [35]. 
2.2.6. Labeling the viral membrane with R18 
To label the viral envelope with lipophilic fluorescent dye, 5 µL of the virus 
solution, 250 µL of MES buffer, and 4 µL of 0.01 mg/mL ethanol-dissolved octadecyl 
rhodamine B (R18) [Invitrogen, Carlsbad, CA] were mixed together in a vial. The 
mixed solution was gently sonicated in a water bath for 30 min at 25°C in the dark.  
Unincorporated R18 dye was filtered out using a G-25 sephadex spin column [GE 
Healthcare, Pittsburgh, PA] at 3000 RPM (743 RCF), and the eluted virus solution 
was stored in a LoBind vial [Eppendorf, Hamburg, Germany] to prevent loss of viral 
particles to vial surfaces while conducting the experiments. Before use, 250 µL of 
filtered virus solution was diluted with 1 mL of MES buffer. Note the labeling of 
virus with membrane dyes has already been shown to not affect HA function [104, 
105]. 
2.2.7. Determining the virus concentration and size 
The stock X-31 virus solution at an initial viral protein content of 2 mg/mL was 
diluted to 0.016 mg/mL. The virus solution was loaded into a flow chamber used in 
the NanoSight system (Malvern Instrument, Worcestershire, UK). Videos of particles 
floating in the solution were analyzed using the NanoSight software to extract the 
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virus concentration. 
2.2.8. Setting the camera rate and experiment time 
SPT studies face an unusual sensitivity to the image capture rate of SPT microscopy 
[58]. Sensitivity is attributed to the fact that a continuous time data of binding events, 
which could last anywhere from 0 to infinite time, are being sampled via a camera 
taking images at discrete time intervals with a set exposure time. Similar issues are 
explained by the Shannon Nyquist Sampling Theorem [106] and Bally et al. [58]. 
Short term binding events will inevitably be lost during the dead time between 
images, which means the overall binding event data will be affected by the camera 
setting. Increasing the imaging rate (by shortening the dead time) is not always viable 
as this would lead to excessive dye photobleaching issues and loss of data about 
long-term binding viruses. The camera setting was thus set according to the minimum 
binding residence time resolution desired relative to a reference time scale. We set the 
reference time scale based on that of virus-mediated de novo clathrin mediated 
endocytosis (CME), which takes roughly 3 min [107]. To encompass the CME 
timescale, camera was set to take images at 1 s intervals using a 100 ms exposure time 
for a total duration of 20 min (tmovie = 20 min).  
2.2.9. Conducting SPT binding experiments 
Labeled viruses were loaded into a SLB-coated microfluidic channel at a flow rate 
of 100 µL/min for 1 min. The flow was stopped by balancing the tube inlet and outlet 
pressures, which takes at most 1 minute to equilibrate. Stagnant flow conditions are 
necessary to prevent shear forces from affecting the binding/unbinding kinetics, 
especially of concern for weak binding interactions. Videos were recorded 1 min after 
the virus was introduced and the flow was stopped. The excitation laser was turned 
off in-between images during the 900 ms dead time to prevent excessive 
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photobleaching of fluorophores while recording the video. After experiments, a 20 vol 
% bleach solution was sent into the microfluidic channels to inactivate viruses. All 
experiments were performed at 25°C. 
2.2.10. Restoring images and tracking particles in SPT videos 
Shot noise from SPT videos was removed using our image restoration algorithm 
called STAWASP, to stand for Segmented Temporal Averaging While Avoiding 
Synced Pixels. Details about STAWASP are provided below. Particles were detected 
using a custom algorithm that looks for circular regions that are brighter than the 
background noise intensities. Particles’ trajectories were determined using a basic 
algorithm that links particles from adjacent video frames together that are within 3 
pixels away from each other. Any remaining and obvious errors in trajectories were 
corrected manually to increase the overall data accuracy, though the number of 
manually corrected trajectories constitutes a small portion of all trajectories returned 
by the automated tracking algorithm.  All algorithms were developed using 
MATLAB (Mathworks, Natick, MA). 
2.2.11. Defining a “binding event” via visual cues 
  Unlike SPR/QCM where the adsorbed mass to a surface can be detected, or AFM 
where binding force can be measured, SPT relies on visual cues that a binding event 
has occurred. These visual cues are not always obvious as virions can undergo 
stop-and-go motions. There are two criteria that can be used: Criteria 1 – a visible 
virus is always considered bound, or Criteria 2 – a visible virus that is immobile for at 
least a minimum duration time (tcutoff) is considered bound. With Criteria 1, a mobile 
virus is treated as only 1 binding event regardless if this particle stops at and moves to 
several places. The concern with Criteria 1 is that the more interesting “stopping” 
events are ignored and the virus may not always be in contact with the SLB while 
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moving. For instance, the virus could be rolling along the SLBs, unbinding and 
rebinding to receptors, or simply floating near the field of view of TIRF without 
making contact. With Criteria 2, a single mobile virus can generate multiple binding 
events when it remains temporarily immobilized during the stop-and-go motion.  
While Criteria 1 may be more appropriate only when studying the lateral diffusion 
of viruses into coated pits [108], we used Criteria 2 because an immobile virus is most 
certainly bound to the SLB. In this regime we are then corresponding most closely to 
the biological situation of virus binding events that lead to de novo CME occurring at 
stationary sites [109]. However, we must decide a minimum binding time for a 
binding event (tcutoff), otherwise there would be no visual cue to discern a bound virus 
from a floating virus. We chose a tcutoff of 5 frames (or 5 s) based on the performance 
of the automated particle tracking software. Note that the choice to tcutoff will always 
be arbitrary because we are relying on visual cues, and not physical contact, to discern 
binding event. Ideally, we would want to capture events upon contact with the 
smallest tcutoff possible. Furthermore, the camera exposure time and frame rate set a 
minimum cutoff time. We later investigate how the choice of tcutoff affects the binding 
data.  
2.2.12. Filtering biased binding events  
When analyzing the binding residence time distributions, some binding events must 
be discarded due to ambiguity or bias. Particles that existed since the first frame 
(left-censored data) of the video were discarded since the actual binding time is 
uncertain. Those that bound after half of the movie time (½ tmovie) were also discarded 
because binding events that last longer than ½ tmovie cannot be observed in a fair 
manner as those that last for shorter times. Virions that stayed bound by the end of the 
movie (right-censored data) were included in the data if they initially bound before ½ 
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tmovie. Due to the filtering of biased binding events, binding survival curves are drawn 
only up to ½ tmovie. 
2.3 Results and discussion 
2.3.1. Establishing conditions for high-quality SLBs 
There are several ways to form SLBs: Langmuir Blodgett, lipid film rehydration, or 
vesicle rupture [65]. When using microfluidics, the vesicle rupture strategy is an 
effective means to form SLBs as it simply requires loading solutions of lipid vesicles 
into the channels. However, such method has previously been reported to cause 
low-quality SLBs if the devices are plasma cleaned [110]. To overcome this issue, 
which can be especially problematic when studying weak binding interactions, we 
determined conditions at which high-quality SLBs form with very minimal defects 
that viruses bind nonspecifically to by optimizing vesicle concentration and SLB 
formation time. Some issues with using lower vesicle concentrations are the creation 
of defective SLBs that induce nonspecific binding and spontaneous virus fusion (Fig. 
3a), most likely due to interaction with edges of SLB patches. Defective SLBs like 
these could be useful for developing antiviral surfaces and may be worth exploring as 
a future work. However, since the focus of this work is on studying binding 
interactions, we sought conditions for reducing nonspecific binding events. Using at 
least 1 mg/ml vesicle concentration worked well. The SLB formation time is also 
important and can vary based on pH or salt [111], lipid compositions [112], and glass 
surface treatment [113]. For our SLBs, at least 3 hours were needed to reduce 
non-specific binding of viruses to negligible levels (Fig. 3b). Additional blocking 
steps were not required since SLBs themselves act as passivation layers. Dye-labeled 
bovine serum albumin, which is a typical blocking agent, did not bind to these 
bilayers to any detectable level (data not shown). Furthermore, inclusion of blocking 
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agents could instill uncertainty, as one must confirm that these do not coat the 
receptors, coat the viruses, or disrupt the SLB. 
 
Figure 3 Optimizing SLB formation to reduce nonspecific binding. a) SLBs were 
formed over 30 min using 1% aGM1 receptor-less lipid vesicles at varying 
concentrations (white text). X-31 nonspecifically bound and spontaneously fused to 
SLBs (as noted by the radial release and diffusion of R18 into the supported bilayer) 
formed with low vesicle concentrations. b) The SLB formation time (white text) was 
varied while maintaining a constant 1 mg/mL vesicle concentration. Nonspecific 
binding was reduced greatly when SLBs are formed over at least 150 min. All images 
in panel a and b, were taken 30 min after loading the X-31 virus. 
 
2.3.2. Controlling for long-range nonspecific electrostatic binding 
Controlling long-range, electrostatic interactions is essential for ensuring that the 
observed binding events are due to specific virus-receptor interactions. The net charge 
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varies across aGM1 (0 charge), GM1 (-1 charge), GM3 (-1 charge), and GD1a (-2 charge). 
To maintain the same receptor concentration and charge density of the bilayers, 
charged lipids must be added. Negatively-charged POPG lipids were added to 
equalize the negative charge density across all the SLBs (Table 1). Positively charged 
lipids could also be used to neutralize charges from the lipids, but since viruses are 
negatively charged, clusters of positively charged lipids could potentially induce 
non-specific binding. The surface charge of the virus must also be monitored, as the 
usage of too much lipophilic dye R18, which is positively charged, could change the 
polarity of the virus surface. The zeta potentials of all lipid vesicles and dye-labeled 
X-31 virus were negative and less than 5 mV in magnitude (Table 1). These 
magnitudes are much lower than 30 mV zetapotentials that could lead to nonspecific 
electrostatic attraction/repulsion between the virus and receptors [114]. The high salt 
content of the buffer also helps screen the charges. Long-range, nonspecific 
interactions are unlikely to play a major role in the viral binding kinetics here, 
enabling us to focus more on measuring the binding of viruses to their putative 
receptors. 
 
Table 1. Zeta potential measurements of vesicles and viruses. suv = small 
unilamellar vesicles. 
Sample Zeta potential (mV) 
1% aGM1   2% POPG   97% POPC 
suv -3.45±0.50 
1% GM1    1% POPG   98% POPC 
suv -3.32±0.59 
1% GM3    1% POPG   98% POPC 
suv -4.60±1.19 
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1% GD1a    0% POPG  99% POPC 
suv -3.47±0.73 
X-31 virus with R18 -2.02±0.26 
X-31 virus without R18 -10.11±0.55 
 
2.3.3. Introducing STAWASP image restoration algorithm for SPT 
Shot noise is rooted in low-signal, digital images due to the discrete photon 
collection method of digital cameras and complex electronic signal amplification 
hardware. In SPT videos, the airy rings of dim particles are barely larger than 2x2 
pixels, making them nearly indistinguishable from noise. There are three major image 
restoration approaches: spatial, temporal, and spatio-temporal filtering. Spatial 
filtering removes static noise pixels based on how abnormal a pixel’s intensity is 
compared to neighboring pixels. This method could produce artifacts such as particle 
blurring. Temporal filtering evaluates how pixel intensity changes over time to 
remove high-frequency noise fluctuation. However, it can cause particles to become 
blurred or faded. Spatio-temporal filtering combines aspects from both approaches, 
but this could become computationally expensive if it requires tracking local spatial 
regions over time.  
Our STAWASP image restoration method can be classified as a spatio-temporal 
filter, and the algorithm is explained in Fig. 4. In short, this algorithm removes noise 
and preserves particle signals by averaging images (or stacking images) together in 
spatially and temporally-divided pixel segments. The unique feature of this algorithm 
is the method at which segments are determined with little input about what is or is 
not a particle. Segments are determined based on how synchronous a cluster of pixels 
fluctuates with time. For instance, the chance all 13 pixels in a circular area (Fig. 4a) 
synchronously increase intensity from one frame to the next is improbable due to 
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random noise and highly probably if a particle appears/disappears/moves. Pixels that 
change intensity synchronously are marked as “synced pixels” (Fig. 4b). Each pixel in 
the 2D image is then averaged through time, but the averaging is done in segments 
separated by the appearance of synced pixels (Fig. 4c). 
 
Figure 4. STAWASP algorithm. a) A local cluster of pixels (gray pixels) must either 
increase or decrease in intensity between consecutive frames to be classified as 
synced pixels. The pixel cluster size must be larger than a pixel and smaller than the 
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particle of interest. Here, at least 80% of the gray pixels must be synced. b) The steps 
to determine synced pixels are portrayed here for a particle appearing at frame 6. 
Since synced pixels are determined using two adjacent frames, synced pixels are 
marked on both of those frames. Note that false synced pixels can be generated by 
random noise fluctuations, but these do not necessarily cause a false particle to 
appear. c) The intensity trace for the center pixel of the particle images part B is 
shown when using STAWASP or the regular 10-frame temporal averaging scheme. 
With STAWASP, temporal averaging is performed in a segmented fashion such that 
temporally-adjacent, synced pixels are not averaged together.  
 
2.3.4. Comparing the performance of STAWASP 
The performance of the STAWASP image restoration was compared against other 
common methods, using a first simulated, noise-ridden video of binding particles 
(Fig. 5). The signal-to-noise ratios (SNRs, defined here as the particle peak intensity 
divided by the standard deviation of the noise intensity) were varied between 0.5 to 5. 
The Mean, Median, and LoG (Laplacian of Gaussian) noise filters intermittently 
revealed particles with SNRs > 2.2, whereas particles with SNRs < 2.2 were 
undetectable. The 10-frame temporal averaging method was able to reveal particles 
with SNRs > 1.1, but all the particles faded in and out of view. The STAWASP 
algorithm was able to reveal particles with SNRs > 1.1, and it preserved the 
appearance/disappearance times of particles with SNRs > 2.2.  
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Figure 5. Testing various image restorations on a simulated movie. A simulated 
movie with noise was generated to compare image restoration performance (see 
Supporting Materials 1.3 for simulation details). The pure video shows particles with 
varying intensities appearing at frame 20 and disappearing after frame 33. Noise is 
added according to the function N = -0.2ln(R), where R is a uniform random number 
from 0 to 1. The SNRs of the 9 particles, from top left to bottom right are as follows: 
5.0, 4.4, 3.9, 3.3, 2.8, 2.2, 1.6, 1.1, 0.5. The LoG (Laplacian of Gaussian) spatial 
filtering method is described by others [89, 115].  
 
No image restoration is perfect, and a common artifact of the STAWASP algorithm 
are short-lived bright pixels throughout the movie, which is a result of the inability to 
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distinguish a small cluster of bright noise from an actual particle. These artifacts are 
dealt with later by the particle detection and tracking algorithms that filter out false 
particles (or shot noise that looks like particles) based on the criteria for a real binding 
event, as discussed above. We use a custom tracking algorithm that links particles 
together within 3 pixels between frames. Since determining the improvement of 
tracking in real SPT videos is difficult due to the inability to know the “true” binding 
events, we instead used a simulated video of particles and noise to assess the overall 
improvement in tracking. In short, STAWASP-restored videos enabled our SPT 
software to extract binding residence time curves that converges to the true data for 
when tcutoff > 5 s, whereas the true data is not obtainable without any restoration. Note 
that for actual SPT videos involving X-31 viruses, we manually correct any obvious, 
erroneous trajectories to increase the accuracy of the data. 
2.3.5. Applying STAWASP for real X-31 virus binding videos 
We next show real images of viral binding before and after using STAWASP image 
restoration (Fig. 6). The clarity provided by the restored image is critical for obtaining 
accurate number statistics of viral binding. A qualitative assessment of the virus 
binding microscopy images shows that X-31 binds most frequently to GD1a, less 
frequently to GM3, and negligibly to GM1. The control case shows a minimum level of 
nonspecific binding of X-31 to aGM1 SLBs, which confirms high-quality SLBs were 
formed inside microfluidic channels. The binding levels of virus to aGM1 bilayer also 
serves to characterize nonspecific binding levels, which can be contributed either by 
microdefects in the SLBs or denatured HA proteins that can insert hydrophobic 
residues into the SLBs. 
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Figure 6. Sample images of viruses binding to glycolipids with and without image 
restoration. Few examples of restored particles are shown by the colored triangles. 
The white number shows the particle count, Pcount, for the right half of each image, 
which represents a physical size of 82 µm high x 41 µm wide using 512 x 256 pixels. 
Note that Pcount is not the same as N. We show Pcount for qualitative comparisons only, 
since quantitative comparisons must be done using N instead, which is determined 
after the particle linking step. The time on left is the video recording time, which 
starts ~60 s after the virus is loaded, and therefore some virus exists at time 0. We 
show images starting at 10 s merely because the performance of STAWASP is 
optimal after 10 frames. We provide original movies without any image restoration 
for the first 300 s as supplemental files, played at 10x real time where 1 frame = 1 
second. STAWASP-enhanced movies are provided for X-31 binding to GM3 (S5 
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Video) and GD1a (S6 Video). Variations in particle intensities are caused by several 
factors, such as variable levels of dye that incorporated into the viral membrane, 
different degrees of photobleaching, and uneven microscope illumination (viruses in 
the center are generally brighter than those near the edges). 
Some interesting observations from the SPT videos are surface-diffusing viruses. As 
mentioned in the Methods section, surface-diffusing viruses can be a result of rapid 
binding/unbinding events, tethered virus to mobile receptors, or rolling viruses. There 
are higher levels of surface-diffusing viruses in GD1a bilayers compared to GM3 
bilayers. The most likely explanation seems to be that the “diffusion” is actually 
rebinding events happening in rapid succession. For GD1a, a virus rebinding to the 
bilayer is a highly probable event due to favorable binding interactions. For GM3, the 
rebinding probability is much lower, and thus virus particles are more likely to float 
away from the field of view rather than bind to an adjacent site. The other 
possibilities, either that the virus is rolling or moving with a few attached glycolipids, 
seem less likely because the virus is much larger than a lipid and the GD1a receptor 
density is too high. There are roughly 420 receptors per pixel (assuming a lipid 
occupies 0.61 nm2 [116] and 1 pixel = 25600 nm2), hence it would difficult for a virus 
to traverse long distances without forming immobilizing, multivalent bonds. 
2.3.6. Analyzing the binding frequency rate and rate parameter kon 
Before discussing the virus binding kinetic data, we must first clearly define 
variables associated with SPT data analysis, as summarized in Table 2.  
 
Table 2. Variables involved with SPT data analysis 
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Variable Definition 
Pcount Number of particles detected in an image 
N Number of binding events 
N+ 
Accumulated number of binding events since the movie 
started 
N- 
Accumulated number of unbinding events since the movie 
started 
t Time elasped in the movie 
tres 
Binding residence time (or contact time) of virus to 
receptors 
tcutoff 
Minimum binding residence time required for a binding 
event 
tmovie Total duration time of the SPT video 
 
Note that N ≤ Pcount (unless tcutoff = 1 frame) because not all particles seen in the 
movie satisfy the binding event criteria that a particle must remain immobile for 
longer than a certain cutoff time. Furthermore, when discussing SPT data, 
distinguishing normal time t and residence time tres is important. For instance, N vs t 
plots portray the net number of binding events as a function of time, whereas N vs tres 
plots portrays how many binding events last longer than tres time (which is a survival 
function).  
We first analyzed the N vs t plots for X-31 binding to the SA receptors. N is related 
to the other variables by the equation N(t) = N+(t) –N-(t) + N0, where N0 is the N 
when the movie starts. The N(t) data clearly shows that GD1a bilayers have a higher 
capacity to hold onto viruses (Fig. 7a, blue line), versus other receptors. One 
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interpretation of the slowly rising net virus binding curve of GM3 (Fig. 7a, green line), 
relative to GD1a’s curve, is to say GM3 is not a functional receptor. In fact, SPR studies 
concluded that GM3 is not a receptor for X-31 [64], though the authors studied viruses 
binding to lipid vesicles instead of SLBs, using half the GM3 concentration than what 
was used here, and while applying a slight hydrodynamic flow that could prevent 
weak binding events. However, having a dN/dt ~ 0 does not mean there is no binding 
rate, similar to how when a system reaches equilibrium, a forward/reverse reaction 
still exists.  
 
Fig 7. Two types of binding rate data of X-31 to various receptors. A) N vs t plots 
for one representative data set from a triplicate set. Negative time means time before 
recording, and the solid black lines are just an extrapolation to -60 s when the viruses 
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are estimated to first reach the SLBs. B) N+ vs t plots, averaged over a triplicate set of 
data. The slope of this plot corresponds to binding frequency rate Ron. The error bars 
are the standard deviations, computed using 3 different trials.  
 
The N+ vs t plots (Fig. 7b) show that X-31 does in fact bind more frequently to GM3 
than to aGM1 and GM1. The slope of the N+ vs t plots yields the binding frequency rate 
Ron, and Ron for GM3 is 3 STDs higher than that of aGM1 and GM1 cases. Our data 
suggest that GM3 can be a functional receptor for the virus.  
Despite GD1a and GM3 each having a terminal SA known to promote binding [71], 
X-31 binds to GD1a ~30 fold more frequently than to GM3. This cannot be explained by 
the presence of 2 SA per GD1a molecule, as spatial distances between SA do not allow 
them to bind to 2 binding sites of an HA trimer (Fig. 8), including alternative binding 
sites located at the HA1/HA2 junction [117]. Additionally, the lack of binding of 
X-31 to GM1’s internal SA suggests that the virus is not binding to the same internal 
SA in GD1a. The extended distance of terminal SA from the SLB hydrophobic layer 
appears to promote binding. Access to GM3’s internal SA may be sterically hindered 
by the close proximity of terminal SA to the bilayer. 
 
Figure 8. Using structural arguments to understand binding results. Left) View 
of HA protein head group in relation to GD1a. Red regions show the binding pockets 
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and yellow circles show where sialic acid are located. Right) Side view of HA protein 
in relation to GD1a. Teal molecules are sialic acids at potential secondary binding sites. 
The SLB would be on the bottom side of the protein, while the viral membrane would 
be on the top side. The hemagglutinin structure and sialic acid positions were obtained 
by Sauter et al. [117] PDB ID: 1HGG. 
 
Binding rates are often characterized via a binding rate constant kon, but SPT data do 
not provide a single value for kon as we will discuss the reasons for later. Starting with 
the standard approach for finding a single kon value, the kon parameter can be solved 
for via the relation Ron = kon[V][SA]Acam where Acam is 6274 µm2 for our camera field 
of view, [V] is the visible virus concentration in the bulk solution, and [SA] is the 
surface density of free receptors in the SLB. Since Ron is determined using early time 
points of the experiment, this enables the assumptions that [SA] and [V] are 
approximately equal to initial values right when the virus is loaded into the channels. 
Therefore we can treat [SA] ≈ [SA]init and [V] ≈ [V]init to estimate the binding rate 
constant kon. The concentration [V]init is ~4.5 pM based on Nanosight measurements, 
and the receptor surface density [SA]init is ~16500 µm-2 for 1 mol % assuming a lipid 
occupies 0.65 nm2 [116]. With these constants, the values for kon are (4.4±3.6)x102,  
(5.5±2.0)x102, (2.1±0.9)x103, and (6.0±2.1)x104 1/Ms for aGM1, GM1, GM3, and GD1a 
respectively, when using the binding event criterion tcutoff = 5s. The kon values for GM3 
and GD1a are within the expected range found by other binding assays, which have 
reported kon = 2x103 M-1s-1 for multiple HAs binding to fetuin [118], kon = 3.61x104 
M-1s-1 for soluble HA binding to GD1a [119], and kon = 1.6x106 M-1s-1 for X-31 virion 
binding to vesicles containing 0.5 mol% Neu5Acα2-3nLc4Cer [64]. 
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We now discuss why there can be multiple values of kon and caution against the 
direct comparison of kon from SPT assays to ensemble assays. Both kon (or Ron) 
depend on the choice of tcutoff because tcutoff dictates how many binding events are 
included in a data set (Fig. 9a). For instance, by setting tcutoff to be infinite, no binding 
events will exist that meets this requirement, hence, kon à 0. Conversely, setting tcutoff 
to be 0 would make kon seem to diverge to infinite because there will be no distinction 
between a binding event, elastic collision, or floating virus that is simply visible on 
the camera. Since the chance for a binding event to exceed a certain tcutoff value is 
dictated by the binding residence time distribution, this means a relationship between 
kon and koff exists and the two parameters are not entirely decoupled as one would 
normally expect. In other words, the ability to observe a binding event is affected by 
the ability of the virus to stay bound long enough to be observed. To understand this 
relationship, we generated a plot for SPT data, that relates  Ron (which is directly 
proportional to kon) to the choice for  tcutoff (Fig. 9b).This plot also serves to facilitate 
the comparison of binding data taken across various tcutoff settings. 
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Figure 9. Observing how binding kinetics changes with choice of tcutoff for a 1 % 
GD1a trial. a) N+ vs t at varying tcutoff settings shown in the legend. b) Ron vs tcutoff plot 
showing how Ron is affected with tcutoff choice. 
 
2.3.7. Analyzing the binding residence time distribution and unbinding 
parameter koff 
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We next analyze the N vs tres plots that portray information about the binding 
residence time distribution and unbinding rates (Fig. 10a). The unbinding curves did 
not agree with the 1:1 binding model (Eq. 1), and double exponential fit model (Eq. 
2).  
Eq. 1 : single binding energy population 
)exp(0 restoffkNN −=  
Eq. 2 : double binding energy populations 
),exp(,0),exp(,0 restBoffkBNrestAoffkANN −+−=  
	
	
39	
	
 
Figure 10. Representative X-31 binding survival curves and empirical fits. a) The 
number of virus bound, N, is plotted against the residence time, tres, to yield a survival 
curve for binding. The Eq. 3 fit parameter for GM3 is [A = 0.87, B = 0.19] and GD1a is 
[A = 2.56, B = 1.38]. The Eq. 4 fit parameters for GM3 is [A = 2.14, B = 1.63] and 
GD1a is [A = 2.06, B = 1.72]. Note that the Eq. 4 fit parameters differ from those found 
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from the related log plots in panel c. The binning of the binding data in the log plots 
causes an approximation error. b) Log plots used to derive Eqn 3. c) Log plots used to 
derive Eqn 4 as used Bally et al.[58] (the data has been binned).  
 
Rather, N decays in an unusual logarithmic fashion with respect to tres, as also 
noticed by norovirus binding kinetics studies [58, 59] and our recent work with 
parvovirus binding to transferrin receptors [102]. Alternative analytical models are 
generally lacking for multivalent binding systems and recent studies have begun to 
address this issue [58, 59, 62, 102, 120]. Here, we searched for an empirical model to 
describe the overall unbinding probability of the virus by testing various log plots 
between N and tres until a linear relationship was found (Fig. 10b and 10c). Two 
possible fit equations for N vs tres are provided (Eq. 3 and 4). Note that Eq. 4 mimics 
the approach used by Bally et al. [58], while Eq. 3 is developed by us and also 
describes the binding residence distribution of parvovirus binding to transferrin 
receptors [102].  
Eq. 3 : empirical fit derived from Fig 10b 
( ) A
t
restBNN
−
Δ
= ln)exp(0  where ∆t is a reference time interval ≤ tcutoff. We used ∆t = 1s 
based on the time interval between images. Note that all equations here apply only 
when tres  ≥ tcutoff.  
Eq. 4 : empirical fit derived from Fig. 10c and proposed by Bally et al [58] 
( )[ ]AtArestABNN −−−−−= 1011 )exp(10  if A ≠ 1  
⎥⎦
⎤
⎢⎣
⎡
−=
0
ln)exp(10 t
restBNN  if A = 1 
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Unbinding rates are often characterized via an unbinding constant koff, which in turn 
is related to binding force. Since Eq. 1 and 2 failed to fit our data, this suggests that 
the unbinding kinetics does not follow a constant koff value, complicating matters. We 
thus assumed koff is not a constant and could vary with tres. To extract koff, we equated 
the empirical fits with the 1st order dissociation equation ( dN/dt = -kofft ) and solved 
for koff. The resulting equations for koff are shown as Eq. 5 or 6  
Eq. 5: koff(tres) based on Eq. 3 
⎟
⎟
⎠
⎞
⎜
⎜
⎝
⎛
Δ
=
t
rest
rest
A
restoffk
ln
)(  
Eq. 6: koff(tres) based on Eq. 4 
( )AtArestA
B
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restoffk −−−
−
−
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)exp(1
)exp(
)(   if A ≠ 1 
0
ln)exp(1
)exp(
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t
restB
tB
restoffk
res
−
=
−
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Since koff is a function of tres, this would imply that the binding force changes 
depending on the contact time between the virus and receptor. This is in good 
agreement with recent work by H. Witt and coworkers showing that binding force of 
multivalent bonds does change with contact time [121]. For viruses, the general term 
for increasing binding force over time is adhesion-strengthening [99-101], which 
includes co-receptor binding, conformational changes of viral proteins, and 
multivalent binding due to receptor diffusion within the target bilayer. Since the HA 
proteins do not significantly change conformation upon binding [117] or under the 
neutral pH conditions used here, adhesion strengthening is thus most likely caused by 
multivalent binding of the virus to the tightly-packed, mobile SA receptors on the 
SLB. In support of this, the estimated number of glycolipids per contact area is ~90, 
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assuming a virus diameter is 150 nm, a lipid molecule occupies 0.61 nm2 of the SLB 
[116], and the contact area is roughly 30% of the virus cross-sectional area based on 
cryo-EM pictures of virus-membrane contacts [122]Furthermore, the glycolipid 
mobility was confirmed by fluorescence recovery after photobleaching (FRAP) 
experiments. 
A competing interpretation of our unbinding curves is that koff spans a wide range of 
values due to a wide distribution of virus sizes and thus degree of multivalent binding. 
To make an empirical model under this interpretation, one would sum many 
exponential functions for 1:1 binding model that are multiplied by a weight function 
that reflection the virus size distribution. This approach would also assume 
multivalent bonds effectively act as a single bond with a stronger binding force. 
However, the virus distribution is narrow and morphology is uniform according to 
particle size and EM studies [35]. Additionally, AFM studies showed complex 
unbinding process [123] that would be inconsistent with the idea that multivalent 
bonds can be treated as a single bond. Overall, the interpretation that koff varies with 
tres because of adhesion-strengthening via multivalent binding is most likely to agree 
with the biology involved in this study. The remaining question is why does koff 
approach infinity if we allow tres to approach 0? Theoretically, this is because as tres 
goes to 0, an elastic collision between virus and membrane will count as a binding 
event, and thus koff will be substantially high to reflect a lack of binding force. 
2.3.8. Bridging SPT and SPR data analysis 
Since protein-ligand binding are currently often studied via ensemble assays such as 
SPR (Surface Plasmon Resonance) and QCM (Quartz Crystal Microbalance), we 
explain how to fit ensemble data using our empirical model from SPT data. Ensemble 
assays collect data on the net adsorbed mass on a surface over time, which would be 
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similar to the N vs t data from our SPT assay. However, unlike SPT assays, ensemble 
assays require two experimental procedures to decouple binding and unbinding 
kinetics, noted as the “association” and “dissociation” phases. The virus must be 
loaded during the association phase to observe both binding and unbinding, and then a 
virus-free buffer is loaded during the dissociation phase to observe mainly unbinding. 
The procedure often requires the virus to be subjected to a gentle hydrodynamic flow 
that could shear off very weakly bound viruses and affect the final data. Also, 
rebinding events that occur during that dissociation phase are difficult to completely 
filter out and could lead to disagreements between expected and actual unbinding 
curves [124].  
With SPT, we can extract association and dissociation curves using stagnant 
conditions and without conducting a separate dissociation phase procedure, simply by 
filtering binding events that occur during the “dissociation phase” that is set at the 
image processing stage. To make SPR-like curves, we plot N vs t, but with few 
differences. N is now set to start at 0 at t = 0 by removing binding events that occurred 
at or before the first frame, and a dissociation phase session is defined to start after 
time tdiss = ½ tmovie, in which new binding events that occurred after that are ignored 
(Fig. 11). 
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Figure 11. SPR-like curve assemble generated from SPT data for the purpose of 
comparing and contrasting the approaches. The fit parameters for Eq. 8 are A = 
2.0, C = 47 (which is greater than Cmin = 16.4). The fit parameters for Eq. 1 are N0 = 
971 and koff = 0.001 s-1).  
 
The unbinding curve can be fitted using a modified form of Eq. 3, which the 
residence time tres is converted into normal time t as shown in Eq. 7. Eq. 7 simply 
states that number of binding events remaining at t > tdiss is the sum of the binding 
events that occurred at t < tdiss and lasted until time t.  
Eq. 7 
∑
Δ−=
=
−
⎥⎦
⎤
⎢⎣
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−
Δ=
ttt
t
A
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diss
t
ttBttRtN
'
0'
'ln)exp()'()(  for t ≥ tdiss 
Since ensemble assays do not yield Ron(t) directly, an simplifying assumption must 
be made. We approximate ∆tRon(t) as a constant, C, based on the N+ vs t plots 
showing a fairly linear relation and constant slope Ron (Fig. 7) This yields the fit Eq. 
8, which would be used if one were given SPR-like data without knowing exactly 
what Ron(t) is. 
Eq. 8 
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C is the number of binding events that occur on average within a time increment ∆t. 
One could instead use a time-varying C fit parameter, C(t), but it may lead to 
over-fitting issues. A lower bound value of C can be set based on the initial slope of 
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the N vs t curve during the association phase, denoted as Cmin. Optimal fit parameters 
can be determined via an iterative search strategy. An example of how our 
adhesion-strengthening model (Eq. 8) performs against the standard 1:1 binding 
model (Eq 1) is shown in fig. 11. The exponential fit model failed to fit the steep drop 
in unbinding immediately after the dissociation phase start, whereas our empirical 
model fitted main features of the curve. 
We assessed of the SPT binding assay platform, image restoration, and data analysis 
for use in virus-membrane binding studies. We developed an image restoration 
algorithm called STAWASP to enhance dim particle signal and improve SPT binding 
data quality. STAWASP restored particles that had a SNR as low as 1.1, and 
preserved appearance/disappearance time of particles with an SNR as low as 2.2. The 
image restoration enabled the SPT software to extract accurate binding residence 
curves when tracking particles lasting at least 5 frames. However, a small number of 
trajectories must still be manually corrected. Fully automated tracking without any 
error is currently not possible and is an active research area for machine-learning 
algorithms. 
We explained data analysis strategies for X-31 binding to various glycolipids, and 
showed X-31 weakly binds to GM3 and to GD1a ~28 times more frequently than to 
GM3, despite both containing terminal sialic acid that should promote receptor binding 
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[71]. On the other hand, ensemble assays and cell infectivity assays had mixed results 
about whether or not the virus can bind to GM3 [64, 98]. The accessibility of SA 
appears highly restricted by the close proximity of it to the SLB lipid core.  
The binding residence distribution curves show an interesting time-dependent koff, 
which is unusual since koff is often assumed to be a constant. The empirical model 
agrees with the interpretation that viruses increase their binding force to host 
membrane with longer contact time via an adhesion-strengthening process. For X-31 
virus, adhesion-strengthening most likely occurs via multivalent bonds that form 
when mobile receptors in the SLBs are recruited to the virus, as opposed to any 
protein conformation changes. We provide a general strategy to apply our empirical 
model to fit ensemble assay unbinding data (Eq. 8) that feature a sharp decline in the 
dissociation curve, followed by a slow decay.  
The combined image restoration and analysis tools developed here is easily 
extendible to other studies that involve imaging low-fluorescence particles binding 
stochastically with surfaces. We have recently applied these tools for tracking 
parvovirus binding to transferrin receptors [102], in which both were labeled with 
limited fluorophores and were difficult to observe without image restoration. Another 
example where this approach could be useful is for studying viruses that undergo 
membrane fusion upon receptor binding (such as parainfluenza). In such case, viruses 
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are usually labeled with a quenched membrane dye and would be difficult to track 
until membrane fusion and dye-dequenching occurs. 
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3.1. Introduction 
Influenza A viruses are enveloped, single-stranded, segmented, negative-sense 
RNA viruses that infect a wide variety of bird and mammalian species. The extensive 
and dynamic genetic diversity of influenza viruses is driven by the frequent 
generation of mutations due to the error-prone viral RNA polymerase and the process 
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of reassortment of gene segments from distinct viruses. Seasonal human influenza 
epidemics result in acute respiratory infections that circulate worldwide and cause up 
to 500,000 deaths each year [126]. Moreover, although they are rare, human influenza 
pandemics can occur when novel subtypes of influenza viruses emerge through 
genetic mutations and reassortment. In these situations, high transmissibility and 
pathogenicity leads to elevated human infections and deaths, as observed during the 
1918 pandemic that led to an estimated 50 million deaths worldwide [127, 128]. The 
1957 and 1968 pandemics, caused by the reassortment of avian and human viruses, 
and more recently, the 2009 pandemic, caused by a triple reassortant between avian, 
swine, and human viruses highlight the importance of the gene reassortment process 
in generating influenza virus strains that exhibit markedly altered tropism, 
pathogenicity, and interspecies transmission characteristics [129, 130]. 
Influenza A viruses require hemagglutinin (HA) and neuraminidase (NA) 
envelope glycoproteins for cell entry and egress, respectively. HA is a trimeric 
membrane-embedded glycoprotein that is a critical determinant of host tropism, and 
mediates both binding to host cell surface sialic acid receptors and fusion of viral and 
host cell membranes. Because of its crucial role in governing cell entry, tissue and 
host tropism, HA is also a key factor in regulating viral pathogenicity. NA protein is a 
tetramer on the surface of virions and is responsible for catalyzing cleavage of 
terminal sialic acids from HA [23, 24]. NA’s functional role is critical for the release 
of progeny viral particles from infected cells at late stages of the infection cycle [25], 
and prevents virus from binding to the mucus overlying the human airway epithelium 
[26]. Influenza A viruses are divided into subtypes based on antigenic and amino acid 
sequence differences of the HA and NA surface glycoproteins, each composed of 18 
and 11 known subtypes, respectively. While different HA and NA combinations are 
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found in circulating influenza viruses, aquatic birds can be infected by most subtypes, 
while humans are known to be infected by three main subtypes: H1N1, H2N2, and 
H3N2 [27]. The human H2N2 subtype is not currently circulating, but was 
responsible for the 1957 pandemic [28]. The avian H5N1 and H9N2 subtypes have 
been recognized for their pandemic potential in the human population [29]. The 
transition of receptor usage from avian-like α2,3-linked to human-like α2,6-linked 
sialic acids represents a critical step for avian viruses to acquire efficient replication 
and transmission capabilities in humans. Furthermore, understanding the effects of 
switching combinations of gene segments that occur during reassortment, in particular 
those encoding HA and NA, is critical for uncovering the basis of emergence of 
influenza viruses with increased pathogenicity and for pandemic preparedness.  
During influenza virus entry, which occurs through the endocytic pathway, 
conformational changes of the HA are critical for virus fusion to occur. HA is a type I 
transmembrane protein and represents a prototypical class I viral fusion protein that 
has been widely studied both structurally and functionally. HA is initially synthesized 
as an uncleaved precursor, HA0, which is proteolytically processed by host cell 
proteases into two subunits, HA1 and HA2, linked by two disulfide bonds. The HA1 
subunit contains a globular domain with residues responsible for binding to sialic 
acids, while the core of the fusion machinery, the hydrophobic fusion peptide, is 
found within the membrane anchored HA2 subunit [20, 33]. The proteolytic cleavage 
event is critical for activating the HA, as it allows for exposure of the fusion peptide. 
In the late endosome, the pH drops from pH 6.5-6 to pH 5-4.5 causing the HA2 fusion 
domain to undergo major conformational changes exposing the fusion peptide and 
enabling it to be inserted into the target endosomal membrane. HA2 then refolds, and 
pulls viral and endosomal membranes together, allowing for hemifusion to occur and 
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ultimately leading to the opening of the fusion pore and release of the viral genome 
[17, 34]. In previous studies, we and others have successfully applied a single-particle 
tracking (SPT) methodology combining total internal reflection microscopy (TIRFM), 
microfluidics, and supported lipid bilayers to study influenza HA-mediated fusion 
kinetics using native viruses or HA-pseudotyped viral particles [35-38]. 
While influenza virus fusion has been well studied, including using the SPT 
approach, the influence of NA on HA fusion function is less clear. In particular, the 
comparison of different HA-NA pairings has not been well characterized in the 
context of HA-mediated fusion. Here, using SPT and a vesicular stomatitis virus 
(VSV)-based pseudotyping system, we investigated how co-incorporation of NA with 
HA in viral particles affects HA-mediated fusion kinetics. The VSV-based 
pseudotyping approach allowed us to focus specifically on the effects of HA-NA 
pairings. We examined the effects of incorporation of the H3 HA and N2 NA of the 
prototypical X-31 strain and compared them with authentic X-31 influenza virus 
fusion kinetics. In addition, to model reassortment of N2 NA, we studied how 
co-incorporation of heterologous human (H2N2 Japan) or avian (H9N2 MS96) N2 
proteins impacts H3 HA-mediated fusion kinetics. The N2 NA gene of the H3N2 
(X-31) subtype is genetically more closely related to the one from the H2N2 (Japan) 
subtype (94.5% amino acid identity) than the one from the H9N2 (MS96) subtype 
(90.5% identity, with 84 amino acid C-terminal deletion) (fig. 12). We show that 
co-incorporation in pseudotyped particles of influenza X-31 H3 and N2 allows higher 
hemifusion kinetics than particles incorporating only H3. Further, the influenza X-31 
H3 and N2 pseudotyped particles exhibited fusion kinetics that closely matched the 
ones observed for authentic X-31 virus. We also demonstrated that co-incorporation 
of X-31 H3 with heterologous N2 from the human H2N2 (Japan) or from the avian 
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H9N2 (MS96) are associated with markedly decreased fusion kinetics, results that 
were consistent with viral phylogenetic relationships, suggesting that even within a 
given subtype there is some degree of constraint imposed by HA-NA pairings with 
respect to HA-mediated function. Finally, we show that the differences in hemifusion 
kinetics we observed could be attributed to changes in relative incorporation of HA 
and NA in viral pseudotyped particles. 
 
Figure 12. (A) Phylogeny of influenza NA genes, including N2 genes from 
A 
B 
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A/Aichi/68-X-31(H3N2), A/Japan/305/57 (H2N2) and A/chicken/Korea/MS96/96 
(H9N2). The phylogenetic tree was generated using the NA amino acid sequences of 
isolated influenza A viruses and with alignments performed with ClustalX 2.1 
(displayed with FigTree) with the Neighbor-Joining method and bootstrap values 
calculated from 2000 trees. Scale bar represents estimated number of substitutions per 
site. Numbers at nodes represent boot strap values. (B) Amino acid sequence 
alignment of influenza A N2. Sequence of A/Aichi/68-X-31(H3N2), A/Japan/305/57 
(H2N2) and A/chicken/Korea/MS96/96 (H9N2). Residues identical to N2 (Japan) are 
left blank. Numbering is based on the N2 (Japan) sequence. The alignment was 
generated using ClustalW in DNASTAR. 
 
3.2. Materials and methods 
3.2.1. Cells, plasmids, and viruses. Baby hamster kidney-21 (BHK-21) cells and 
Madin-Darby canine kidney (MDCK) cells were obtained from the American Type 
Culture Collection (ATCC, Manassas, VA) and grown in Dulbecco’s modified Eagle 
medium (DMEM, CellGro), supplemented with 10% fetal bovine serum (Gibco), 1% 
penicillin and 10 µg/mL streptomycin (CellGro), 1% HEPES buffer (CellGro). The 
cells were cultured in a 37 °C, 5% CO2 incubator.  
The plasmids pCAGGS-H3/X-31, pCAGGS-N2/X-31, pCAGGS-N2/MS96, 
pCAGGS-N2/Japan, pCAGGS-VSVG and pCAGGS-empty were used to transfect 
BHK-21 cells.  pCAGGS-H3/X-31 and pCSAGGS-N2/X-31 encode the 
hemagglutinin and neuraminidase of influenza virus X-31, respectively. 
pCAGGS-N2/MS96 encodes the neuraminidase of influenza virus MS96 (H9N2), 
pCAGGS-N2/Japan encodes the neuraminidase of influenza virus Japan (H2N2), and 
pCAGGS-VSVG encodes the glycoprotein of vesicular stomatitis virus. The 
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pCAGGS vector serves as the empty vector control. Influenza X-31 A/Aichi/68 H3N2 
(Charles River, Wilmington, MA) (live virus) was used as a reference case in the 
study.  
The VSV *G-VSVΔG is a recombinant virus that harbors a genome in which the 
glycoprotein gene is replaced by the green fluorescence protein (GFP) reporter gene, 
and is a generous gift from Michael Whitt from University of Tennessee. 
3.2.2. Preparation of influenza pseudoparticles[131, 132]. 9 × 105 cells BHK-21 
were seeded in 10 cm petri dishes (Corning), and incubated for 24 h. BHK-21 cells 
were transfected by a mixture containing 36 µL of lipofectamine 2000 transfection 
reagent (Thermo Fisher) and 12 µg of plasmid DNA (6 µg of HA- and NA-encoding 
plasmids DNA) for each plate, and incubated for 24 h. Next, transfected BHK-21 cells 
were inoculated with VSV *G-VSVΔG in RPMI medium (10.4 g RPMI powder, 26.7 
mL BSA 7.5% liquid, 25 mL 1 M HEPES, 1 L H2O), and incubated for 2 h at 37°C 
with rocking. Unbound viruses were washed out with DPBS (Dulbecco’s 
phosphate-buffered saline), and incubated for 24 h at 37°C with DMEM growth 
medium. For HA only case, 0.25 units of exogenous neuraminidase from C. welchii 
(Sigma-aldrich) was added to the plate to facilitate viral particle release. The 
supernatants, which contain pseudotyped particles, were collected after several gentle 
taps on the walls of petri dishes to help the release of particles. The supernatants were 
ultracentrifuged in a Ti45 rotor at 35,000 rpm for 120 min. The supernatants were 
discarded, and pellets were resuspended in 3 µg/ml trypsin and incubated for 30 min 
at 37 °C to activate HA. The trypsin-treated viral solutions were then aliquoted for 
storage at -80°C. 
3.2.3. Western blotting. Pseudotyped particles were concentrated using an 
ultracentrifuge at 20,000 rpm in a TiSW28 rotor (Beckman-Coulter) for 2 h at 4°C. 
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The pellets were resuspended in 30 µL of 3 µg/mL trypsin EDTA (Thermo Fisher 
Scientific) solution, and put in 37°C water bath for 15 min. The samples were then 
analyzed by Western blot using goat anti-A/HongKong/1/68 (H3) (NR-3118, BEI 
resources), goat anti-A/shorebird/Delaware/127/1997(N2) (NR-670, BEI resources) 
and mouse anti-VSV-M antibodies (Kerafast) followed by incubation with 
HRP-conjugated rabbit anti-goat IgG (Life Technologies) and HRP-conjugated goat 
anti-mouse IgG (Life Technologies). All Western blots were visualized and analyzed 
using a Chemidoc XRS+ system with Image Lab image capture software (BioRad). 
The Image Lab software was used to quantify intensities of bands using low 
sensitivity setting. The software detects the bands by the signal contrast between band 
and background. We note that all bands have only been adjusted in contrast and 
brightness in the Image Lab software. The software shows the original signal 
intensities of the bands. 
3.2.4. Immunofluorescence assay.  5 × 105 cells BHK-21 cells were seeded in 
8-well glass slides (Millipore). After 24 h, BHK-21 cells were transfected by a 
mixture containing 0.75 µL of lipofectamine 2000 transfection reagent (Thermo 
Fisher Scientific) and 1 µg of plasmid DNA (500 ng of HA- and NA-encoding 
plasmid DNA) for each well, and incubated for 24 h. Transfected cells were then 
fixed with 4% paraformaldehyde (PFA) (Thermo Fisher Scientific) for 15 min and 
PFA was then quenched in 50 mM ammonium chloride (NH4Cl) for 15 min. For the 
permeabilized condition, 0.1% Triton X-100 was added to each well for 5 min at 4°C 
and washed three times with DPBS. The cells then were blocked with 5% normal goat 
serum for 45 min, and labeled with monoclonal mouse anti-HA antibody 
(Sigma-Aldrich), and goat anti-A/shorebird/Delaware/127/1997(N2) (NR-670, BEI 
resources), followed by labeling Alexa Fluor 568-conjugated goat anti-mouse 
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antibody (Thermo Fisher Scientific) and 488-conjugated chicken anti-goat antibody 
(Thermo Fisher Scientific). The nuclei were labeled with DAPI (Southern Biotech). 
Microscopy images were acquired using inverted microscope (Carl Zeiss) with a 63x 
objective. 
3.2.5. Preparation of liposomes. Liposomes used in this study contain a 
4:4:2:0.5:0.01 molar ratio of 1,2,dioleoyl-sn-glycero-3-phosphocholine (DOPC), 
1-oleoyl-2-palmitoyl-sn-glycero-3-phosphocholine (POPC), cholesterol, total 
ganglioside extract (TGE) and Oregon green DHPE, based on compositions found in 
previous studies that provide comparative data[37, 69]. The lipids were purchased 
from Avanti Polar Lipids (Alabster, AL), and Oregon green DHPE was purchased 
from Molecular Probes, Eugene, OR. To form liposomes, all components were 
dissolved and mixed in biotechnology grade chloroform (Sigma-Aldrich) in a glass 
vial. The bulk solvent was first removed by blowing high purity nitrogen and the 
solution was placed in a desiccator under vacuum for 3 h to ensure complete 
evaporation of the solvent. GPMV buffer (50 mM Hepes, 150 mM NaCl, 2 mM CaCl2, 
pH 7.4) was then added to the vial to re-suspend the dried lipid film to create a 5 
mg/mL solution. Liposomes were then extruded ten times through a 100 nm pore size 
polycarbonate filter (Whatman Nucleopore), and five times through a 50 nm pore size 
filter.  
3.2.6. Fluorescent labeling of viruses. Both influenza viruses and the influenza 
pseudoparticles were labeled with the lipophilic fluorophores: octadecylrhodamine B 
chloride (R18), a red-emitting fluorophore, at a sufficient concentration and sonicated 
30 min to quench fluorescence.  
3.2.7. NA inhibition assay. The neuraminidase inhibitor 
N-Acetyl-2,3-dehydro-2-deoxyneuraminic acid (NADNA) (Sigma-Aldrich) was 
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dissolved in DI water to 2 mg/mL. 1 µL of NADNA was mixed with 6 µL of 
influenza X-31 virus and incubated at 37 °C for 1 h. The NADNA-treated virus was 
labeled as described in the labeling procedure and fusion carried out at selected 
triggering pH’s.  
3.2.8. Preparation of glass surfaces for supported bilayers. To produce biomimetic 
planar supported lipid bilayer, researchers have developed various methods[48, 133, 
134]. Here, self-assembling of lipid vesicles was performed to form a host 
cell-mimetic membrane bilayer, and the procedure is described as follows. Glass 
microscope coverslips (25 mm × 25 mm; No. 1.5) from VWR were cleaned in piranha 
solution (45 ml 50% hydrogen peroxide and 105 ml 70% sulfuric acid) for 10 min 
then rinsed 30 min with deionized water with a minimum resistance of 18.2 MΩ cm 
(Siemens Purelab Ultra water purification system). Glass slides were flushed by 
deionized water again and dried by a stream of ultra-pure nitrogen gas prior to plasma 
cleaning.  
3.2.9. Fabrication of microfluidic devices. The generation of microchannel silicon 
mold developed using soft lithography was published previously [36, 48, 69]. The 
pattern contains six trenches 70 µm deep, 135 µm wide and 1.5 cm long with 100 µm 
spacing between each channel. Microfluidic devices were formed using 
polydimethylsiloxane (PDMS) in a molding process. The silicon mold was coated 
with chlorotrimethylsilane (Sigma-Aldrich) via vapor deposition to facilitate the 
release of cured PDMS. A 10:1 (elastomer:crosslinker) mixture of Sylgard 184 (Dow 
Corning) was mixed and degassed to remove bubbles before pouring on the silicon 
mold. The PDMS then was crosslinked in the oven for 3 h at 80 °C. Both the piranha 
cleaned glass cover slip and the microfluidic device were assembled by oxygen 
plasma bonding. They were first treated with oxygen plasma using a Harrick Plasma 
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Cleaner (Model # PDC-32G, Ithaca, NY) at a pressure of 750 millitorr on the “high” 
setting for 15 s. The two pieces were then pressed together gently to form a tight bond 
and annealing was performed at 80 °C for 15 min.  
3.2.10. Forming supported bilayers in microfluidic channels. A 10% dilute 
solution of liposomes was drawn into the microchannel at a flow rate of 100 µL/min 
for 90 s and incubated on the glass substrates for 2 h. The microchannel was then 
rinsed with the GPMV buffer at 100 µL/min for 2 min. To heal defects in membranes, 
a 5% dilute solution of liposomes was drawn into the microchannel at 10 µL/min for 5 
min. Before loading virus-containing solutions, channels were rinsed again with 
GPMV buffer at 100 µL/min for 2 min. 
3.2.11. TIRF microscope configuration. Single-particle fusion assays were operated 
using total internal reflection fluorescence microscopy (TIRFM) with an inverted 
Zeiss Axio Observer.Z1 with an α Plan-Apochromat 100× oil immersion objective 
with a numerical aperture (NA) of 1.46. Index-matching immersion oil (Carl Zeiss, 
Inc.) was added to the glass coverslip of the microfluidic device and the objective. 
Two lasers with 561 nm and 488 nm excitation wavelengths were used to 
simultaneously excite red and green fluorophores under this setting. The Laser TIRF 3 
slider (Carl Zeiss, Inc.) was used to control the angles of incidence in the optical 
pathway. Exceeding the critical angle (~62°) generates total internal reflection due to 
the difference in refractive indices of the two different substances (glass and aqueous 
buffer), and further creates an evanescent wave that penetrates about 100 nm into the 
aqueous buffer. Because virion binding and fusion occurs within a ~100 nm thick 
region, the evanescent wave can excite fluorophores near the membrane and eliminate 
the background noise from viruses floating in the bulk aqueous phase.  
3.2.12. Image processing. Membrane fusion events were analyzed using both ImageJ 
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(NIH) and MATLAB (Mathworks). Each fusion event was manually selected in 
ImageJ with Time series analyzer V2.0 plugin, and the intensity of each event in 4 × 4 
pixels was averaged and saved with the corresponding time as a table. The data was 
then processed by MATLAB to calculate the fusion lag time and used to fit the lag 
times into a gamma-distribution equation to retrieve the fusion rate constant [37]. 
 
3.3. Results 
3.3.1. Influenza pseudotyped particle production and infectivity assays. To assess 
the effect of HA-NA pairings on infectivity of influenza pseudotyped viruses, six 
types of pseudotyped particles were produced: HA only pseudoparticles (H3X-31), 
native matching pseudoparticles (H3X-31/N2X-31), human:human mismatching 
pseudoparticles (H3X-31/N2Japan), human:avian mismatching pseudoparticles 
(H3X-31/N2MS96), and two control pseudovirions, VSV-∆env and VSV-G.  
The pseudovirions were then used to infect Madin-Darby canine kidney epithelial 
(MDCK) cells, with infection confirmed by the green fluorescence signals produced 
by the infected cells. In all cases, MDCK cells were evenly seeded at 2 × 105 
cells/cm2, so more GFP-positive cells indicate that pseudovirions had higher 
infectivity (Fig. 13). VSV-Δenv refers to particles without envelope glycoproteins 
(negative control case) and VSV-G are particles harboring the VSV G surface fusion 
protein (positive control case). The results of the infectivity assays show that 
VSV-H3X-31/N2X-31, VSV-H3X-31/N2Japan VSV-H3X-31/N2MS96 and VSV-H3X-31 
particles are infectious, as GFP-positive cells were observed in all these cases. 
However, among these, infectivity levels varied based on the number of GFP-positive 
cells observed. To better understand the basis for the differences in infectivity 
observed, we carried out single-particle fusion assays to determine if there were 
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differences in cell entry behavior among these particles. 
 
Figure 13. Top row: MDCK cell infectivity assay of influenza pseudotyped particles 
H3X-31/N2X-31, H3X-31/N2Japan, H3X-31/N2MS96, H3X-31, VSV and Δenv. Green 
fluorescence indicates infection of the cell. Bottom row: bright field images of the 
images above. 
3.3.2. Single-virion fusion experiments. To monitor virus entry and fusion at the 
single particle level, individual virion fusion measurements were performed using 
total internal reflection fluorescence (TIRF) microscopy. Microfluidic channels were 
coated with supported lipid bilayers (SLB) (Fig. 14). The SLB contained a mixture of 
zwitterionic lipids, cholesterol, total ganglioside extract (TGE), and Oregon green 
DHPE[37, 69]. TGE contains glycolipids that possess sialic acid groups necessary for 
influenza binding. Oregon green DHPE is a pH-sensitive fluorophore embedded in the 
SLB that drastically decreases in emission intensity when exposed to an acidic 
solution, marking the time when HA-activating acidification occurs in the 
microfluidic channel. The fluidity of SLBs was confirmed by using fluorescence 
recovery after photobleaching (FRAP) performed prior to the fusion assay. Membrane 
fluidity of SLBs can affect the hemifusion kinetics and is thus a crucial parameter to 
control when comparing the rate of fusion between assays[35, 69]. The average 
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diffusion coefficient for three samples was determined to be 0.847 ± 0.03 µm2/s which 
corresponds to the value measured in a previous study[69]. 
 
 
 
Figure 14. Top illustration: Single-particle fusion assay performed with total internal 
reflection fluorescence microscope (TIRFM). Three pseudovirus particles are shown 
containing HA (blue) and NA (red) in their membrane envelopes. The center virus is 
bound to sialic acid (purple) in the supported lipid bilayer (gray) localizing the virus 
in the ~100 nm evanescent wave (green) that results from the total internal reflection 
of laser light at the glass-buffer interface. The evanescent light excites the 
fluorophores in the viral membrane, emitting in red. Viruses outside the evanescent 
field are not excited, and thus no red emission is observed. Note that a 
membrane-bound pH sensor (Oregon green DHPE) is not shown for clarity. Bottom 
row: images of a native X-31 virus labeled with R18 fusing with a supported bilayer 
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after triggering with pH 4.5. 
HA-mediated membrane fusion is a multistep reaction that begins with hemifusion 
(the merging of the outermost leaflets of the host and viral membranes). Hemifusion 
commences when hemagglutinin is exposed to an acidic solution, which triggers 
major conformational changes of the viral envelope protein. Pseudovirions were 
treated with TPCK-trypsin for 15 min at 37˚C in order to cleave the precursor HA0 
into HA1 and HA2, which is an essential activating step for successful membrane 
fusion to occur[20]. To track the fusion reaction and its intermediate steps, viral 
membranes were labeled with quenched amount of octadecyl rhodamine B chloride 
(R18). Upon membrane hemifusion, the membrane dye that originated in the viral 
envelope spreads into the SLB and dequenches as the fluorophores diffuse radially 
away from the hemifusion site, an event that is easily detected by a CCD camera (Fig. 
14, bottom). Fusion experiments were carried out within a channel for 3-4 min at a 
data collection rate of 10 frames/s. 
The hemifusion lag time is defined as the interval of time between the pH drop 
and hemifusion for each individual virion. Within the field of view, hemifusion is 
marked by individual dequenching events. The lag time distributions are fit to the 
cumulative gamma distribution: 
𝑝! =  𝑘!!𝑡!!!𝛤(𝑁)!! 𝑒!!!! 𝑑𝑡 
where kH is the hemifusion or pore formation rate constant, t is lag time, and N is an 
additional fit parameter reporting the number of rate-limiting steps. In the context of 
fusion kinetics, N is often correlated to the number of HA trimers that must act 
concertedly to initiate fusion[37], but is mathematically defined as the number of 
steps in the pathway. The gamma distribution is appropriate here, as fusion events 
occur stochastically and independently of each other. Each fusion event is a multistep 
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process, with each step in the process being described by a Poisson process. The 
gamma distribution is a convolution of multistep Poisson processes.  
We characterized the hemifusion behavior of native influenza X-31, 
native-matching pseudoparticles (H3X-31/N2X-31), human:human mismatching 
pseudoparticles (H3X-31/N2MS96), human:avian mismatching pseudoparticles 
(H3X-31/N2Japan), and HA only pseudoparticles (H3X-31) over a range of initiation pHs. 
Figure 15 illustrates hemifusion rates by showing the cumulative gamma distribution 
data at the upper and lower limits of HA conformational change activation, pH 4.5 
and pH 5.1, respectively. At pH 4.5 and 5.1, the rate of hemifusion of native influenza 
X-31 and matching pseudoparticles (H3X-31/N2X-31) are similar and are distinctively 
faster than that of other pseudoviruses, including the HA only pseudoparticles 
(H3X-31).  
The hemifusion kinetics over a range of initiation pHs between pH 4.0 to pH 5.1 
were determined (Fig. 15). The hemifusion rate constants of samples at the tested pH 
in ascending order are HA only pseudopaticles (H3X-31), mismatching pseudoparticles 
(H3X-31/N2MS96), mismatching pseudoparticles (H3X-31/N2Japan), matching 
pseudoparticles (H3X-31/N2X-31) and native influenza X-31. The hemifusion rate 
constants of matching pseudoparticles (H3X-31/N2X-31) and native influenza X-31 are 
similar at all initiation pHs. The hemifusion kinetics of native influenza viruses is 
strongly dependent on pH as well as matching pseudoparticles (H3X-31/N2X-31). The 
rate of hemifusion increases almost linearly from pH 5.3 to 4.7 and reaches a plateau 
at the “fastest” fusion pH. It is not evident from the data shown in figure 16 that 
mismatching pseudotyped particles (H3X-31/N2MS96) exhibits the same dependence on 
pH. While the maximum rate of fusion of mismatching pseudovirions (H3X-31/N2MS96) 
also occurs at pH 4.7, the error associated with the parameter falls within the rate 
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constant values associated with adjacent pHs, thus it can be concluded that the 
hemifusion kinetics of mismatching pseudotyped particle (H3X-31/N2MS96) is triggered 
by acidification but rate independent of triggering pH. pH independent influenza 
fusion rate is not unprecedented, as we also observed a similar flat trend for a clinical 
isolate, A/Brisbane/2007/H3N2 [35]. 
 
Figure 15. Cumulative distribution function plot of different batches of native 
influenza X-31, matching pseudoparticles (H3X-31/N2X-31), mismatching 
pseudoparticles (H3X-31/N2Japan), mismatching pseudoparticles (H3X-31/N2MS96), and 
HA only pseudopaticles (H3X-31) at pH 4.5 and 5.1.  
The number of HA trimers (N) required for pseudotyped particle fusion was also 
calculated and compared with that of native influenza X-31 (Fig. 16). At high, 
physiological pH values, N values for influenza virus X-31 and matching 
pseudovirions (H3X-31/N2X-31) are found to be approximately 3, while the N values of 
human:human mismatching pseudovirions (H3X-31/N2Japan) vary between 1.5 to 3. A 
few possible interpretations of this variation include a change in the number of HA 
contributing to bending the membrane over this range, but this is hard to rationalize 
with our understanding of the fusion process. It may reflect that other processes are 
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dominating the kinetics in this regime, but it also seems at odds with what we know 
about hemifusion, that there would be such oscillations among rate limiting steps 
within this range.  What seems most likely to us is considering that N is an 
exponential fit parameter; it gives rise to an inherent sensitivity in data fluctuations 
and thus produces a wider range of output values. Considering that the authentic X-31 
does not have such variation in its fits for N, we may attribute these fluctuations as 
resulting from variations among the particles themselves: the HA incorporation in 
VSV pseudotypes are lower than the authentic influenza X-31, or that the morphology 
of the rhabdoviral pseudovirions are bullet-shaped compared to the spherical 
morphology of authentic X-31. For human:avian mismatching pseudotyped particles 
(H3X-31/N2MS96) and HA-only pseudopaticles (H3X-31), N is consistently closer to 
unity as a function of pH. These findings suggest that only one HA trimer may be 
needed for mismatching pseudotyped particle fusion. However, since hemifusion is a 
multi-step process, an N value equal to 1 more likely indicates that another process 
less dependent on viral particle properties, e.g. the merging of membranes, may occur 
so slowly that kinetics are dominated by this single step, thus resulting in a gamma 
distribution where N = 1 [135].  
 
Figure 16. HA hemifusion kinetics. Hemifusion rate constant, kH and number of HA 
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trimers, N, as a function of pH for native influenza X-31, matching pseudoparticles 
(H3X-31/N2X-31), mismatching pseudoparticles (H3X-31/N2Japan), mismatching 
pseudoparticles (H3X-31/N2MS96) and HA only pseudoparticles (H3X-31). The error bars 
of the data represent the standard deviation of at least three separate experiments. 
Dashed lines serve to guide the eye only.  
 
3.3.3. Incorporation of HA and NA in pseudovirions. Previous work done by 
Bosch et al., has demonstrated that the presence and activity of NA was key to HA 
incorporation into lentiviral-based pseudotyped particles and their release from the 
cell surface [136]. In order to understand better the differences in fusion kinetics 
observed among matching (H3X-31/N2X-31) and mismatching pseudovirions, 
quantitative Western blots were performed to determine the relative protein 
incorporation of HA in particles. The internal VSV matrix protein (M protein, ~37 
kDa) was used to normalize band intensities of HA. The three hemagglutinin bands 
include one uncleaved HA (HA0) at 75 kDa and the cleaved HA (HA1 and HA2) at 50 
kDa and 25 kDa, respectively (Fig. 17). HA1 bands were normalized to corresponding 
VSV M bands to calculate the cleaved proportion of HA protein in different samples. 
The normalized bands were normalized again to the HA1 bands of HA only 
pseudoparticles (H3X-31) so the values could be compared between different HA-NA 
combinations. HA band intensities of human:avian mismatching pseudoparticles 
(H3X-31/N2MS96) and human:human mismatching pseudoparticles (H3X-31/N2Japan) are 
~45% and ~20% lower than X:31 matching pseudoparticles (H3X-31/N2X-31), 
respectively. Considering that a successful viral fusion event may require at least 
three HA trimers, a lower density of HA trimers on mismatching pseudoparticles may 
explain the slower fusion rate we have measured. 
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N2 bands (~55 kDa) were detected by Western blot (except in HA only 
pseudoparticles (H3X-31)). Three N2 bands were normalized to corresponding VSV M 
bands to calculate the NA density on different samples. The normalized bands were 
normalized again to the matching pseudovirions (H3X-31/N2X-31), and the quantitative 
analysis indicated that normalized N2 bands intensity were similar in the three 
pseudoparticle types containing it.  
 
Figure 17. Quantification of intensities of HA, NA and VSV M protein by Western 
Blot (A). The HA1 (B) and NA (C) band intensities were directly detected by 
Chemidoc XRS+ imager and normalized to corresponding M band intensity to obtain 
the relative HA and NA expression levels on different VSV pseudotyped particles. 
Each error bar represents the mean ± SD of three independent experiments. NA 
protein was also detected except for HA only particles. 
 
3.3.4. HA and NA expression in transfected cells. During production of 
pseudoparticles, cells were transfected with the same amount of HA- and 
NA-encoding plasmids DNA (6 µg), but HA incorporation levels in each type of 
particle varied, while NA stayed relatively constant, as shown in the Western blot 
analysis [137]. Hence, an immunofluorescence assay was used to monitor HA and NA 
trafficking in BHK-21 cells. 24 h post transfection, HA, NA, and cell nuclei were 
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fluorescently labeled in permeablized and non-permeablized conditions (Fig. 18). 
Staining in the permeablized condition gives an assessment of the HA and NA 
localization in the cell, while the non-permeabilized condition shows cell surface 
expression of the viral proteins.  
In the permeablized condition (top three panels), HA accumulated mostly 
within perinuclear vesicles in HA-only (H3X-31), mismatching (H3X-31/N2MS96) and 
mismatching (H3X-31/N2Japan) conditions. In matching transfected cells (H3X-31/N2X-31), 
HA was found to accumulate in perinuclear patches that extended throughout the 
cytoplasm. The NAs were found being expressed more diffusely in cells than X-31 
HA. No NA signal was observed in the HA-only (H3X-31) condition, as expected.  
In the non-permeablized condition (bottom three panels), the different NAs 
and the X-31 HA could be observed co-localizing at the cell surface in most cells. 
Cells co-transfected with matching H3X-31/N2X-31 displayed the strongest cell-surface 
expressed HA labeling. H3X-31/N2Japan co-transfected cells had slightly less bright 
cell-surface HA labeling, followed by H3X-31/N2MS96 co-transfected condition and 
cells without NA transfection had the lowest cell-surface HA expression.  
Overall, the immunofluorescence microscopy results are in alignment with the 
report by Galloway et al. which also compared the expression of H3 in X-31 
HA-transfected cells with and without cognate N2, and showed that NA influences 
trafficking of  HA to the cell surface in BHK and Vero cells [138]. Taken together, 
these results indicate that the matching NA is required for efficient HA trafficking to 
the plasma membrane, which is the site of virion budding for both native influenza 
and VSV pseudotyped particles. Danieli et al. and Lee et al. suggest that an influenza 
A virus requires at least three HA trimers to be close to each other to form a 
hemifusion site [135, 139], which indicates that the density of HA trimers affects the 
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hemifusion rate of influenza A virus. The immunofluorescence analysis shown here 
confirms the Western blot HA densitometry data and suggests that NA plays an 
important role in expression and intracellular trafficking of HA, and that even within 
the same subtype (N2), different NAs can influence cell-surface expression of HA. 
 
Figure 18. Expression and subcellular localization of HA and NA in HA-NA 
co-transfected BHK-21 cells by immunofluorescence microscopy assay. Cell nuclei 
were labeled with DAPI (blue), and HAs/NAs were labeled with anti-HA (clone 
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HA-7) and anti-N2 (H6N2) primary antibodies and with corresponding 
fluorophore-conjugated antibodies (false-colored with HA in green and NA in red). 
Top three rows: permeabilized BHK-21 cells imaged using 100× objective. Bottom 
three rows: non-permeabilized BHK-21 cells using 100× objective and with identical 
exposure time. For each panel, cells were co-transfected with pCAGGS-H3(X-31) and 
with either (from left to right): pCAGGS-empty (No NA), pCAGGS-N2 (X-31), 
pCAGGS-N2(Japan) (Japan N2 NA), and pCAGGS-N2(MS96) (MS96 N2 NA). 
Scale bar represents 10 µm. 
3.3.5. Effect of NA inhibition on hemifusion kinetics. Influenza NA has an 
important role during progeny virus egress from host cell by enzymatically cleaving 
sialic acids and facilitating the release of viral particles [17, 140, 141]. Here, our 
immunofluorescence assay result suggests that heterologous N2 proteins modify H3 
trafficking in HA-NA co-transfected cells, and can lead to a decrease in HA 
incorporation levels in VSV pseudotyped particles. Single-particle fusion analyses 
reveal that the rate of hemifusion decreased significantly with lower surface HA 
protein expression level [142]. 
In order to assess whether the enzymatic activity of NA plays a role in these 
observations, we used N-Acetyl-2,3-dehydro-2-deoxyneuraminic acid (NADNA), a 
known inhibitor of NA, to block the neuraminidase activity on influenza X-31 (Fig. 
19). The data demonstrates the hemifusion kinetics of NADNA-treated influenza 
virus and non-treated virus are similar at pH 4.0 and pH 5.1, and there were no 
significant differences on viral binding either. The hemifusion rate constant of NA 
inhibitor treated virus is 0.24 s-1 with a value of 2.5 for N at pH 4, and 0.06 and 1.9 at 
pH 5.1. That NADNA does not affect hemifusion kinetics of the virus follows the 
conclusions of Ohuchi et al.’s work[142], where they also found that NA inhibitors do 
	
	
71	
	
not impact either binding or fusion; however, they suggest that NA function does 
impact endocytosis, and in this way, impacts “entry”. Since the SPT assay presented 
here isolates binding and fusion processes from endocytosis, our results corroborate 
Ohuchi et al.’s observations and reinforces our conclusion that differences in 
expression level (HA/NA) balance among particles is important for the fusion 
process.  
 
 
Figure 19. Cumulative distribution of hemifusion events at pH 4.0 and pH 5.1 for 
NADNA-treated influenza X-31 and non-treated influenza X-31. 
 
3.4. Discussion 
The ever-evolving diversity of influenza virus strains, particularly those of avian 
origin, represents a pressing concern for global health. While it is well known that 
mutations and the reassortment of gene segments generates this diversity, 
understanding the consequences of different combinations of viral genes, particularly 
those encoding HA and NA still awaits further elucidation. Some studies have shown 
that a functional balance of HA and NA is required for virus replication[143] and that 
insufficient NA enzymatic activity leads to the formation of virus aggregates on 
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egress [144]. Here, we have investigated how incorporation of different NAs affect 
the fusion function of the HA protein and provide more evidence for a potential role 
for NA during entry and glycoprotein transport. 
Using a VSV-based viral pseudotyping approach we were able to specifically 
study the interplay between HA and NA. This system allowed us to study the 
co-incorporation of H3 HA and N2 NA of the prototypical strain X-31 and to switch 
N2 NAs of different strains. We produced four different types of influenza 
pseudoparticles: pseudoparticles containing HA only (H3X-31), X-31 HA and NA 
matching pseudoparticles (H3X-31/N2X-31), and to model N2 NA gene reassortment, 
human:human mismatching pseudoparticles (H3X-31/N2Japan) and human:avian 
mismatching pseudoparticles (H3X-31/N2MS96). Particles that incorporated both X-31 
HA and NA displayed distinctly higher fusion kinetics than those harboring HA only. 
Further, we show that the X-31 matching pseudoparticles (H3X-31/N2X-31) exhibit 
similar hemifusion kinetics than native influenza X-31. Other combinations of 
particles display different kinetics from the native particles.  
The significant decrease of hemifusion rate between influenza X-31 and 
mismatching pseudoviruses could be explained by the variations in HA incorporation 
on the pseudotyped particles when different NAs were co-transfected [136, 138], a 
hypothesis confirmed by quantitatively analyzing HA1 bands in Western blot assays 
performed on concentrated pseudotyped particles. However, the degree of NA 
incorporation by Western blot showed that the densities were similar for the three 
different NAs in the pseudoparticles. These results are also supported by the 
immunofluorescence microscopy assay that shows that HA trafficking varies 
considerably depending on which NA is co-expressed in transfected BHK-21 cells, 
leading to differential HA expression on cell plasma membranes, whereas NA 
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expression does not seem as affected. These analyses demonstrate that NA does not 
act directly on HA function but rather has an indirect effect by modulating the 
trafficking and incorporation of HA into pseudotyped viral particles. Our work shows 
that switching NAs of the same subtype (N2) can have profound effect on fusion 
kinetics mediated by the HA protein. This study suggests that HA-NA combinations 
form pairs of varying compatibility that can ultimately impact HA fusogenicity. In 
summary, we show that influenza X-31 H3 HA requires its matching neuraminidase 
to maximize the HA packaging density on VSV pseudoparticles, and the matching 
pseudoparticles exhibit similar hemifusion kinetics as influenza X-31 by single virion 
fusion assay. 
Beyond this study, there are some directions worth pursuing next. First, defining 
the pore formation of VSV pseudoparticles is an important step to understanding the 
impact of HA-NA balance on genome transfer. From previous studies we know that 
the pore formation kinetics of influenza H3N2 is described by a simple single 
exponential decay (one step transition from hemifusion intermediate to open pore) [35, 
37] which begs the question if pseudovirus particles behave in the same way, or if 
HA-NA balance may impact this process as well. The SPT fusion platform has been 
useful for screening the HA neutralizing antibodies [145]. We note a recent 
development of a high-throughput, microdroplet-based single particle hemifusion 
assay [146, 147] that is a potentially powerful tool to screen antibodies could be also 
useful in expanding the studies presented here to characterize many phenotypes 
quickly based on hemifusion function. 
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4.1. Introduction 
Influenza viruses are membrane-enveloped, single-stranded, negative sense 
segmented RNA viruses of the family Orthomyxoviridae. In order to deliver their 
genomic viral RNA segments into host cells, influenza viruses must accomplish 
several key steps through specific virus-host interactions that are mediated by cell 
surface receptors and viral envelope proteins. Influenza A viruses harbor two distinct 
envelope glycoproteins: hemagglutinin (HA) and neuraminidase (NA), for cell entry 
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and egress, respectively. HA is a trimeric membrane-embedded glycoprotein that is a 
critical determinant for host tropism as it mediates both binding to host cell surface 
receptors and fusion of viral and host cell membranes. HA is composed of two 
subunits, HA1 and HA2, where HA1 governs binding to target cells, while HA2 
governs membrane fusion by conformational rearrangement that exposes the fusion 
peptide. Importantly, HA requires proteolytic activation by host cell proteases to 
become fusion-competent, a priming event that occurs between the HA1 and HA2 
subunits.  
The first step of influenza virus entry is the binding of HA1 to host cell receptors, 
α-sialic acids (α-SA), an event that triggers endocytosis of the virion [17]. During 
maturation of the endosome, the internal pH decreases. The acidic environment 
triggers major conformational changes in HA, leading to exposure and release of the 
fusion peptide found at the N-terminal extremity of HA2 [148]. The fusion peptide 
then inserts into the target endosomal membrane and further conformational changes 
pull the viral and endosomal membranes together until they merge. During this 
process of membrane fusion, an intermediate structure is formed, the hemifusion stalk, 
where only the outer leaflets of the two opposing membranes are fused. Eventually 
the hemifusion intermediate collapses and forms an expanding fusion pore, where 
influenza genomic RNAs are released into the cytoplasm allowing viral replication to 
ensue [17, 34]. Moreover, viral fusion depends on the characteristics of the host cell 
in various ways, e.g. host protease expression profile [29, 149], the progression of 
endosomal acidification [138], and properties of host cell membrane [150].  
Influenza A viruses are divided into subtypes based on antigenic and amino acid 
sequence differences of the HA and NA surface glycoproteins, each composed of 18 
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and 11 known subtypes, respectively. HA subtypes H1-H16 and NA subtypes N1-N9 
are found in avian species, while humans are known to be infected by three main 
subtypes: H1N1, H2N2, and H3N2. However, other virus subtypes including H5N1, 
H7N2, H7N3, H7N7, H9N2, H10N7, H7N9, H6N1, H5N6, and H10N8 have been 
found to be able to infect humans, with avian H5N1, H7N9 and H9N2 subtypes 
recognized for their pandemic potential in the human population [151-153]. 
Transmission of AIV to humans is controlled by binding avidity preferences towards 
different types of α-SA [17]. Among other factors, AIV more preferentially binds to 
α2,3 galactose-linked SA and less so to α2,6 galactose-linked SA. On the surface of 
epithelial cells in the upper respiratory tract of humans, there are high levels of 
α2,6-SA receptors and low levels of α2,3-SA receptors. Moreover, α2,3-SA receptors 
are present predominantly in the lower respiratory tracts of humans[154]. In contrast, 
α2,3-SA receptors are more readily found in epithelia of avian species [155, 156]. 
Despite differences in binding avidity towards α-SA, AIV is still considered an 
important pathogenic threat for humans. The major concern is that AIV can 
accumulate mutations that would enable the virus to acquire efficient replication and 
transmission capabilities in humans, which may lead to an influenza pandemic.  
Pandemic influenza remains a serious threat to human health globally due to the fact 
that it is unpredictable and can result in millions deaths [157]. Vaccinations and 
antiviral drugs are effective control measures for influenza, however, the frequent 
emergence of novel influenza viruses and the emergence of resistant strains 
complicate their implementation. Hence, the Influenza Risk Assessment Tool (IRAT) 
was developed by the Centers of Disease Control and Prevention (CDC) to evaluate 
the pandemic potential of newly emerging influenza viruses. IRAT builds a 
framework which weighs 10 risk elements and the top three weighted elements are 
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human infection, transmission (laboratory animals), and receptor binding [40]. 
However, there is evidence that besides virus receptor binding properties, virus fusion 
properties might also play a role in virus pandemic potential [35, 41, 138, 158-163]. 
Russier and colleagues showed changes in the pH of activation for HA of the 
pandemic influenza virus (pH1N1) during its inter-species transmission from swine to 
humans [41]. The HA activation pH decreased significantly when it transmitted from 
swine (activating pH > 5.5) to early human cases (pH 5.5), which further decreased in 
human isolates characterized later in the pandemic (pH 5.4-5.2). Galloway et al. 
reported that the HA activation pH of human seasonal viruses is closer to pH 5.0 
[138]. Costello et al. further reported that at single-virion level, the HA of a clinically 
relevant strain, H3N2 (Brisbane), was observed to be able to maintain its fusogenicity 
for the longest time at low pHs (pH 5.1-4.5) compared to the egg-adapted strain 
(Udorn), and the laboratory-adapted strain (X-31) [35]. Furthermore, influenza has 
also been shown to adapt to enhance its ability to remain fusion-competent in lower 
pH environments (HA structural stability) [159, 163]. Because the human airway 
tissue constitutes an acidic environment (pH 5.5-6.9) [42, 43], both these adaptations 
boost the success of infecting these host cells. These findings highlight and promote 
the importance of taking into account changes in HA activation pH and ability to 
persist in acidic environments (structural stability) when evaluating the pandemic 
potential of newly-emerged influenza virus strains [162, 164]. 
In this study, we focus on the emergence of a recent influenza strain which was 
initially  characterized in a human case in 2013 in Jiangxi Province, China (strain 
A/Jiangxi-Donghu/346/2013(H10N8), or H10N8 (JX346)) [165]. JX346 has been 
reported to be less pathogenic in poultry, but its infection in humans was found to be 
lethal [166]. So far, three human cases have been reported, two of which were fatal, 
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suggesting that future cases of human infection with H10N8 may be associated with a 
high fatality rate [167]. An additional concern arose from the observation that, after 
several passages of an avian H10N8 strain in the lungs of mice, the passaged viruses 
became more virulent and resulted in the death of the animals [168]. Although to date 
there have been few reported human H10N8 infections and deaths, it is important to 
characterize in detail this strain, as it could represent a future pandemic threat [169]. 
To assess one critical aspect of pathogenicity, we examined the fusogenicity of JX346 
HA by cell-cell fusion and single-particle hemifusion assays. In single-particle 
hemifusion assay, murine leukemia virus (MLV)-based pseudotyping system was 
performed as the surrogate of influenza H10N8 (JX346). Previously, we have shown a 
similar influenza pseudotyping system can recapitulate the hemifusion characteristic 
of native virus at the single-virion level[170]. The single-particle hemifusion data on 
JX346 HA presented here, unveils distinct HA fusion attributes that govern viral entry 
and could impact transmissibility and govern pathogenicity and pandemic potential. 
With this work, we reinforce the importance of characterizing fusion attributes of 
emergent strains like H10N8 influenza virus for a more complete assessment of 
pandemic potential. 
4.2. Materials and Methods 
4.2.1. Cells plasmids and antibodies. African green monkey kidney Vero-E6, human 
embryonic kidney HEK-293T, and Madin-Darby canine kidney (MDCK) cells were 
obtained from the American Type Culture Collection (ATCC, Manassas) and grown 
in Dulbecco’s modified Eagle medium (DMEM, CellGro), supplemented with 10% 
fetal bovine serum (Gibco), 1% penicillin and 10 µg/mL streptomycin (CellGro), 1% 
HEPES buffer (CellGro). The cells were cultured in a 37 °C, 5% CO2 incubator. 
pCMV3-H10N8-JD-13-HA(JX346), pCMV3-JD-13-NA(JX346) plasmids were 
	
	
79	
	
purchased directly from Sino Biological (EPI497479 for N8; EPI497477 for H10).  
pCMV3-H10N8-JD-13-HA(JX346), pCMV3-H10N8-JD-13-NA(JX346), 
pCMV-MLVgag-pol, and pTG-Luc plasmids were used to transfect HEK-293T cells 
for pseudotyped particle production. pCMV3-H10N8-JD-13-HA(JX346) and 
pCMV3-H10N8-JD-13-NA (JX346) plasmids were cotransfected along with 
pCMV-MLVgag-pol and pTG-Luc to produce H10N8 pseudotyped particles. 
pCMV-MLVgag-pol encodes the retroviral core proteins of murine leukemia virus 
(MLV), and pTG-Luc transfer vector encodes a luciferase reporter gene with a 
packaging sequence. pCAGGS-VSV-G encodes the glycoprotein (G) of the vesicular 
stomatitis virus (VSV) and pCAGGS empty vector were used to generate positive and 
negative control-pseudotyped particles, respectively.  
Polyclonal anti-H10 sera was produced by immunizing a rabbit (Rockland) with 
purified, baculovirus-derived H10 HA (Sino Biological) 
4.2.2. H10 expression characterization. The H10 HA expression in Vero cells were 
assessed using both immunofluorescence assay and western blotting.  5 × 105 cells 
Vero-E6 cells were seeded in 8-well microscopy glass slides (Millipore). After 24 h 
cells were transfected with a mixture containing 0.75 µL of Lipofectamine 2000 
transfection reagent (Thermo Fisher Scientific) and 1 µg of plasmid DNA (500 ng of 
H10-encoding plasmid and 500 ng N8-encoding plasmid) or 500 ng of H10-encoding 
plasmid for each well, and incubated for 24 h. Transfected cells were then fixed with 
4% paraformaldehyde (PFA) (Thermo Fisher Scientific) for 15 min and PFA was then 
quenched in 50 mM ammonium chloride (NH4Cl) for 15 min. For the permeabilized 
condition, 0.1% Triton X-100 was added to each well for 5 min at 4 °C and washed 
three times with DPBS. The cells then were blocked with 5% normal goat serum for 
45 min and labeled with rabbit anti-H10 (Rockland), followed by incubation with the 
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secondary Alexa Fluor 488-conjugated goat anti-rabbit antibody (Thermo Fisher 
Scientific). Nuclei were labeled with DAPI (Southern Biotech). Microscopy images 
were acquired using inverted microscope (Carl Zeiss) with a 63× objective.  
To further characterize the antibody-antigen interaction specificity, the Vero-E6 cells 
transfected with H10-encoding plasmid and N8-encoding plasmid or transfected with 
empty vector were lysed and analyzed by western blotting. 24 h post transfection, the 
cells were washed once by DPBS and lysed with RIPA buffer (Thermo Fisher) for 15 
min at 4 °C. The attached cells were removed by a cell scraper. The cell lysate was 
then further incubated for 15 min at 4 °C, and the lysate was centrifuged at 13000 × g 
for 5 min at 4 °C to remove cell debris. The supernatant was collected, and denatured 
by incubating with SDS sample buffer (10% 2- mercaptoethanol) for 7 min at 75 °C. 
Samples were then analyzed by western blot using rabbit anti-H10 (Rockland) 
followed by incubation with HRP-conjugated goat anti-rabbit IgG 
(Life Technologies). Western blots were visualized and analyzed using a Chemidoc 
XRS+ system with Image Lab image capture software (Bio-Rad).  
4.2.3. Cell-cell fusion assay [171]. HA stability and membrane fusion were assessed 
by cell-cell fusion assay. 5 × 105 Vero-E6 cells were seeded in 8-well microscopy 
glass slides (Millipore). After 24 h cells were transfected with a mixture containing 
0.75 µL of Lipofectamine 2000 transfection reagent (Thermo Fisher Scientific) and 1 
µg of plasmid DNA (500 ng of H10-encoding plasmid and 500 ng N8-encoding 
plasmid) for each well, and incubated for 24 h. Cells were then treated with 3 µg/mL 
of trypsin for 30 min at 37 °C to activate H10 expressed on the cell membrane. Cells 
were then incubated with a low-pH buffer (5 mM HEPES, 5 mM MES, 5 mM 
succinate, 150 mM NaCl) for 5 min at 37 °C to destabilize the HA and induce fusion. 
Cell-cell fusion was left to proceed for 1 h at 37 °C in DMEM. Cells were then fixed 
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with 4% paraformaldehyde (PFA) (Thermo Fisher Scientific) for 15 min followed by 
quenching with 50 mM ammonium chloride (NH4Cl) for 15 min. The antibody 
labeling procedure was performed as detailed above. Microscopy images were 
acquired using an inverted microscope (Carl Zeiss) with a 20× objective. Syncytia 
were analyzed by counting number of nuclei per syncytium, with at least 9 syncytia 
assessed for each condition.  
4.2.4. Preparation of influenza pseudoparticles. HEK-293T cells were seeded in a 
6-well plate (Corning), and incubated for 24 h. The cells were then transfected with a 
mixture containing 3 µL of Lipofectamine 2000 transfection reagent (Thermo Fisher) 
and 1.3 µg of plasmid DNA (300 ng of H10-encoding plasmid, 300 ng of 
N8-encoding plasmid, 300 ng pCMV-MLVgag-pol and 400 ng pTG-Luc plasmids) in 
each well, and incubated for 48 h [172]. Supernatants containing pseudotyped 
particles were collected after several gentle taps on the walls of petri dishes to help 
release of particles. Supernatants were ultracentrifuged in a Ti45 rotor at 35,000 rpm 
for 120 min and pellets were resuspended in PBS and then aliquoted for storage at -80 
°C. The particles were treated by 3 µg/mL trypsin and incubated for 30 min at 37 °C 
to activate HA right before use[173] 
4.2.5. Liposomes used to prepare supported bilayers. Liposomes  contained 
4:4:2:0.5:0.01 molar ratio of 1,2,dioleoyl-sn-glycero-3-phosphocholine (DOPC), 
1-oleoyl-2-palmitoyl-sn-glycero-3-phosphocholine (POPC), cholesterol, total 
ganglioside extract (TGE) and Oregon green DHPE (pH sensitive marker), based on 
compositions found in previous studies that provide comparative data [37, 69]. The 
lipids were purchased from Avanti Polar Lipids (Alabaster, AL), and Oregon green 
DHPE was purchased from Molecular Probes, Eugene, OR. To form liposomes, all 
components were dissolved and mixed in biotechnology grade chloroform 
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(Sigma-Aldrich) in a glass vial. The bulk solvent was first removed by blowing high 
purity nitrogen and the solution was placed in a desiccator under vacuum for 3 h to 
ensure complete evaporation of the solvent. PBS buffer was then added to the vial to 
re-suspend the dried lipid film to create a 5 mg/mL solution. Liposomes were then 
extruded ten times through a 100 nm pore size polycarbonate filter (Whatman 
Nucleopore), and five times through a 50 nm pore size filter.  
4.2.6. Preparation of glass surfaces for supported bilayers. Glass microscope 
coverslips (25 mm × 25 mm; No. 1.5) from VWR were cleaned in piranha solution 
(45 mL 50% hydrogen peroxide and 105 mL 70% sulfuric acid) for 10 min, then 
rinsed 30 min with deionized water with a minimum resistance of 18.2 MΩ cm 
(Siemens Purelab Ultra water purification system). Glass slides were flushed by 
deionized water again and dried by a stream of ultra-pure nitrogen gas prior to plasma 
cleaning.  
4.2.7. Fabrication of microfluidic devices. The generation of microchannel silicon 
mold developed using soft lithography was published previously [36, 48, 69]. The 
pattern contains six trenches 70 µm deep, 135 µm wide and 1.5 cm long with 100 µm 
spacing between each channel. Microfluidic devices were formed using 
polydimethylsiloxane (PDMS) in a molding process. The silicon mold was coated 
with chlorotrimethylsilane (Sigma-Aldrich) via vapor deposition to facilitate the 
release of cured PDMS. A 10:1 (elastomer:crosslinker) mixture of Sylgard 184 (Dow 
Corning) was mixed and degassed to remove bubbles before pouring on the silicon 
mold. The PDMS was then crosslinked in the oven for 3 h at 80 °C. Both the piranha 
cleaned glass cover slip and the microfluidic device were assembled by oxygen 
plasma bonding. They were first treated with oxygen plasma using a Harrick Plasma 
Cleaner (Model # PDC-32G, Ithaca, NY) at a pressure of 750 millitorr on the “high” 
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setting for 15 s. The two pieces were then pressed together gently to form a tight bond 
and annealing was performed at 80 °C for 15 min.  
4.2.8. Forming supported bilayers in microfluidic channels. To produce 
biomimetic planar supported lipid bilayers, various methods have been developed [48, 
133, 134]. Here, self-rupturing lipid vesicles were generated to form a host 
cell-mimetic membrane bilayer. A 10% diluted solution of liposomes prepared as 
described above in PBS was drawn into the microchannel at a flow rate of 100 
µL/min for 90 s and incubated on the glass substrates for 2 h. The microchannel was 
then rinsed with the PBS buffer at 100 µL/min for 2 min. To heal defects in 
membranes, a 5% diluted solution of liposomes in PBS buffer was drawn into the 
microchannel at 10 µL/min for 5 min. Before loading virus-containing solutions, 
channels were rinsed again with PBS buffer at 100 µL/min for 2 min. 
4.2.9. Fluorescent labeling of viruses. Hemifusion in single particle tracking is 
reported by fluorescence dequenching. For these experiments, influenza H10N8 
(JX346) pseudotyped particles were labeled with a lipophilic reporter called 
octadecylrhodamine B chloride (R18), a red-emitting fluorophore, at a sufficient 
concentration and sonicated 30 min to quench fluorescence. The particles were then 
passed through a MicroSpin G-25 column (GE Healthcare Life science) to remove 
excess R18. The fluorophore-labeled particles were then ready to be flowed into the 
channels for binding and hemifusion assays. 
4.2.10. Single particle hemifusion assay: microscopy. Another method used to 
assess HA stability and membrane hemifusion is single particle tracking of 
hemifusion in supported lipid membranes formed within microfluidic devices. These 
assays were performed using total internal reflection fluorescence microscopy 
(TIRFM) with an inverted Zeiss Axio Observer.Z1 with an α Plan-Apochromat 100× 
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oil immersion objective which has a numerical aperture (NA) of 1.46. Index-matching 
immersion oil (Carl Zeiss, Inc.) was added to the glass coverslip of the microfluidic 
device and the objective. A laser with 561 nm excitation wavelength was used to 
simultaneously excite red fluorophores under this setting. The Laser TIRF 3 slider 
(Carl Zeiss, Inc.) was used to control the angles of incidence in the optical pathway. 
Exceeding the critical angle (~62°) generates total internal reflection due to the 
difference in refractive indices of the two different substances (glass and aqueous 
buffer), and further creates an evanescent wave that penetrates about 100 nm into the 
aqueous buffer. Because virion binding and fusion occurs within a ~100 nm thick 
region, the evanescent wave can excite fluorophores near the membrane and eliminate 
background noise from virions in the bulk aqueous phase. 
4.2.11. Single particle hemifusion assay: experimental execution. R18-labeled 
influenza pseudotyped particles were drawn into the channels and allowed to bind to 
the bilayers for at least 15 min. Unbound particles were rinsed out with PBS buffer at 
a flow rate of 100 µL/min for 90 s. To test the effect of triggering pH on influenza HA 
hemifusion kinetics, acidic buffers (150 mM NaCl, 1.5 mM MES, 5 mM citric acid) 
pre-calibrated over a range of acidic pH values were used. Each solution was 
delivered through a microfluidic channel at a flow rate of 100 µL/min for 120 s to 
acidify the microfluidics device channels and induce membrane hemifusion between 
particles and SLBs. The R18 dequenching spike from particle hemifusion were 
recorded with a CCD camera for 4 min. 
4.2.12. Single particle hemifusion assay: image processing. Membrane hemifusion 
events were analyzed using both ImageJ (NIH) and MATLAB (Mathworks). Each 
hemifusion event was manually selected in ImageJ with Time series analyzer V2.0 
plugin, and the intensity of each event in 4 × 4 pixels was averaged and saved with 
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the corresponding time as a table. The data was then processed by MATLAB to 
calculate membrane hemifusion parameters. 
4.3. Results  
4.3.1. H10 characterization and H10 sera testing. The pCMV3-H10 and 
pCMV3-N8 plasmids were first used to transfect mammalian cells to test the H10 HA 
expression and trafficking with or without N8 NA. Rabbit sera from the H10 
immunized animal (Rockland) was used to detect and confirm the expression of H10 
HA protein in Vero-E6 cells by immunofluorescence (IFA) analysis (Fig. 20A). To be 
sure the antibodies generated from the rabbit sera were specific to H10N8 transfected 
cell lysate, bands corresponding to H10 HA0 (~75 kDa) were analyzed and detected 
by western blot (Fig. 20B).  
 
 
Figure 20. H10 expression and detection in Vero-E6 cells. (A) Expression and 
subcellular localization of HA in H10/N8 co-transfected Vero-E6 cells visualized by 
immunofluorescence microscopy. Cell nuclei were labeled with DAPI (blue), and HA 
was labeled with rabbit anti-H10 followed by AF488-conjugated goat anti-rabbit 
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antibody. Top row: permeabilized Vero-E6 cells imaged using 63× objective. Bottom 
row: non-permeabilized Vero cells using 63× objective and with identical exposure 
time. The scale bar represents 50 µm. (B) Western blot of H10 HA. H10/N8 
transfected cells or mock-transfected cells were lysed. HA was detected by rabbit 
anti-H10 primary antibody and HRP-conjugated goat anti-rabbit secondary antibody.  
 
IFA analysis was conducted to track the trafficking of the HA in the cells. 24 h post 
transfection, HA and cell nuclei were fluorescently labeled in membrane 
permeabilized and membrane non-permeabilized conditions. The permeabilized 
plasma membrane condition shows the location of HA in the cytosol, where the 
antibody can bind to HA present in cell organelles (e.g. Golgi apparatus, ER). We 
found that in the permeabilized condition, HA accumulates mostly within perinuclear 
vesicles when expressed without N8 expression. However, in HA and NA 
co-transfected cells, HA was found to accumulate in perinuclear patches that spread 
throughout cytoplasm. In the non-permeabilized condition, which shows the plasma 
membrane surface expression of the viral proteins, in the absence of N8 NA, the HA 
signal appeared to be weaker at the surface compared to the HA and NA 
co-transfected cells, which showed robust surface expression. 
 
4.3.2. Cell-cell fusion assay results. With the confirmation that we can express H10 
on the surface of cells, we first set out to characterize its fusogenicity using cell-cell 
fusion assays. The goal of these experiments was to determine the pH threshold at 
which H10 starts to mediate membrane fusion. We define this point as the HA fusion 
activation pH, which is an important property of HA that may contribute to a strain’s 
pathogenicity and tropism.  
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Figure 21. H10 fusogenicity characterization. (A) H10N8 cell-cell fusion assay. 
H10 was labeled by rabbit anti-H10 serum followed by anti-rabbit AF488-conjugated 
secondary antibody. Nuclei were stained with DAPI (blue). Syncytia (multinucleated 
cells) can be observed from pH 5.1 to pH 4. The images were obtained by using a 20× 
objective, and the scale bar represents 50 µm. (B) The number of nuclei per 
syncytium were counted and plotted for different pH values. 
 
For these experiments, Vero-E6 cells were co-transfected to express H10 and N8 and 
treated with the HA-activating protease TPCK-trypsin in 8-well glass slides. The cells 
in each well were then incubated in a pH buffered solution ranging from pH 3.5 to 7 
to trigger membrane fusion. Cells were then fixed and labeled with rabbit anti-H10 
sera and with the nuclear stain DAPI so that the formation of syncytia could be 
determined. At the fusion activation pH, formation of syncytia containing multiple 
nuclei were observed. In Vero-E6 cells (Fig. 21A), the first syncytia were observed at 
pH 5.1, with no syncytia observed at pH 5.5 or 5.3. A semi-quantitative analysis was 
used to evaluate the extent of cell-cell fusion that shows that there is an acidic 
	
	
88	
	
pH-dependent increase in the extent of fusion (number of nuclei/syncytium) (Fig. 
21B).  
In order to examine the fusion properties of the H10 (JX346) in more detail, we 
describe results from single particle fusion assays using H10N8 pseudoparticles. 
Single particle hemifusion assay monitors the hemifusion between the outermost 
leaflet of the membranes of an individual pseudoparticle and a host cell. With the 
higher resolution afforded by single particle imaging, we gain additional information 
regarding fusion in the virus entry step, i.e., H10 acid stability (the amount of time 
HA can remain fusion competent in a given acidic environment) and the 
pH-dependent H10 hemifusion kinetics. These features are also potentially important 
aspects of entry behavior that can be assessed for pandemic potential.  
 
4.3.3. H10N8 pseudotyped particle production and infectivity assay. Prior to using 
the pseudovirus particles for single particle fusion assays, we first assessed their 
overall cell infectivity using a luciferase assay. Murine leukemia virus (MLV) 
pseudotyped particles harboring both H10 and N8 proteins and containing the 
luciferase reporter gene were generated. Such pseudotyping approach has been 
successfully used for other envelope glycoproteins such as those of the Ebola virus 
and Middle East Respiratory Syndrome coronavirus (MERS-CoV) [174-177]. After 
the pseudoparticles were harvested, they were used to transduce MDCK cells to test 
the infectivity. The infectivities were measured as relative luciferase units (RLU) 
from the infected cells. The positive control particles harboring VSV-G had an 
infectivity level around at ~1 × 107 RLU. For negative control conditions, both 
non-infected cells and ∆env particles had infectivities of ~1 × 102 RLU, a lower limit 
indicating no infectivity. H10N8 pseudotyped particles have an infectivity level at ~1 
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× 105 RLU. For comparison, H10 pseudotyped particles (no NA) have an infectivity 
level at ~1 × 102 RLU, supporting our previous western blot results that these particles 
have little to no HA incorporated (Fig. 22B). Overall, these results demonstrate that 
the pseudotyped particles harboring H10N8 HA and NA proteins can be successfully 
produced and give rise to robust infectivity in MDCK cells. Furthermore, a western 
blotting assay was conducted to demonstrate the H10 expression on pseudoparticles. 
Figure 22B shows HA0 was barely detected on the pseudotyped particles containing 
H10 only and no HA1 was detected (the left column). However, two bands 
corresponding to H10, HA0 (~75 kDa) and HA1 (~50 kDa), were detected in H10N8 
pseudotyped particles (the right column). After trypsin treatment, the signal for HA0 
decreases and the signal of HA1 increases (the middle column). Together, these 
results show that H10 can be expressed and detected by the rabbit sera in our system 
and that is it necessary to co-express N8 in the particles to ensure presence of H10 in 
the pseudotyped viral particles and their infectivity. These results align with previous 
reports that show that the model human influenza virus (H3N2) X-31 strain requires 
its strain-matched N2 protein co-expression for efficient HA packaging into 
pseudoparticles (and to recapitulate its native virus fusion attributes) [149, 170]. 
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Figure 22. H10N8 pseudotyped particles characterization. (A) Assessment of 
MLV-based pseudotyped particle infectivity by luciferase assay. Four types of MLV 
pseudotyped particles were produced and used to infect MDCK cells. 72 h 
post-infection, infected MDCK cells were lysed and analyzed for luciferase activity 
using a luminometer. The values are the mean with S.D. of triplicate wells. (B) 
Western blot of H10 HA. H10 or H10N8 were expressed on MLV pseudotyped 
particles and detected by rabbit anti-H10 primary antibody and HRP goat anti-rabbit 
secondary antibody. H10N8 pseudotyped particles were treated by 3 µg/mL trypsin to 
cleave HA. 
 
4.3.4. Single-particle hemifusion assay. We monitored individual virion membrane 
fusion events of H10N8 pseudotyped particles with supported lipid bilayers (SLBs) 
using a microfluidic platform coupled with a total internal reflection fluorescence 
(TIRF) microscope. By changing the angle of the incident laser, an evanescent wave 
at the interface between the glass and aqueous buffer can be generated. In this 
configuration, the evanescent wave illuminates a region 100 to 200 nm away from the 
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interface, where viral binding and fusion events on the SLB can be readily monitored. 
The SLB is designed to mimic a host cell surface; it contains phospholipids, 
cholesterol, total ganglioside extract (TGE) for the receptor, and Oregon green DHPE 
as a pH indicator. TGE is a glycolipid that is extracted and purified from porcine brain 
tissue, and contains mainly α2,3-linked sialic acid (SA) and serves as the receptor for 
the virus. Oregon green DHPE is a pH-sensitive fluorophore embedded in the SLB 
that serves as an indicator of acidification of the channel by drastically decreasing its 
intensity when exposed to an acidic solution in the range of pH 4 to 7.  For quality 
control of our supported bilayers, the fluidity of the SLBs was examined by using 
fluorescence recovery after photobleaching (FRAP), and the diffusivity was 
determined to be 0.812 ± 0.01 µm2/s which meets the average diffusivity and mobile 
fractions reported previously [170]. 
To evaluate the hemifusion behavior of influenza H10N8 (JX346), the membranes of 
H10N8 pseudotyped particles were labeled with a red membrane-intercalating, 
quenched dye, octadecyl rhodamine B chloride (R18). Control of the buffer 
environment of the bound particles was readily managed using the microfluidic 
device to precisely control and change different solution conditions. Fusion was 
triggered by acidifying the channel and tested over a range of low-pH buffered 
solutions. Upon membrane hemifusion, the outer leaflets of the virus particles and the 
SLB mix, which results in the R18 that was originally contained in the viral particle 
diffusing radially away from the fusion site in the SLB and consequently dequenching. 
These dequenching events of hemifusion are easily detected and recorded with a CCD 
camera. The resulting video microscopy analysis provides information about the 
hemifusion lag time for each particle, which is defined as the time between the pH 
drop (assessed by the decrease in Oregon green signal) and onset of hemifusion (spike 
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of dequenching) for each individual particle. Once all the hemifusion events are 
cataloged by their time points, the lag time distributions are fit to the following 
cumulative gamma distribution:  
𝑝! =  𝑘!!𝑡!!!𝛤(𝑁)!! 𝑒!!!! 𝑑𝑡 
where pH is the probability of hemifusion, kH is the hemifusion constant, t is lag time, 
and N is an additional fit parameter. N represents the number of independent steps that 
are required for hemifusion to occur. However, within the context of virus fusion, N is 
often assigned as the number of HA trimmers that must act concertedly to initiate 
fusion [37]. kH and N are usually plotted as a function of pH to assess the 
pH-dependence of the hemifusion rate during acidification. Because in a maturing 
endosomal environment, the pH drops, we tested the pH range from the early 
endosome (~pH 6) to the late endosome (~pH 5). The hemifusion lag time can give an 
indication of the timing of virus genome release along the endocytic pathway and 
whether this happens closer to the plasma membrane or the cell nucleus [35]. This is a 
critical step in the influenza virus life cycle, as the genome requires transport into the 
nucleus for replication. Nevertheless, we have previously shown that in terms of 
fusion kinetics, influenza HA- and NA-pseudotyped particles behave almost 
identically to wild type, native viral particles [170], making this approach useful in 
assessing fusion properties of native viruses, so long as the HA and NA are matched. 
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Figure 23. H10 hemifusion kinetics. Hemifusion rate constant, kH and number of 
HA trimers, N, as a function of pH for native influenza X-31, and H10N8 (JX346) 
pseudoparticles. Dashed lines serve for visual guidance only. The vertical dashed line 
indicates the fusion activation pH of JX346. 
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We characterized the fusion behavior of H10N8 pseudotyped particles and compare to 
results for a common egg-adapted influenza strain, X-31 (H3N2) over a range of 
initiation pHs (Fig. 23). The first hemifusion events for H10N8 particles are observed 
at pH 5.1 at single-particle level, which agrees with the previous cell-cell fusion assay, 
where the first syncytia were observed at pH 5.1 as well. Looking at the trends in the 
single particle data, generally, the hemifusion rate constant of H10N8 pseudotyped 
particles increases with decreasing pH, and the hemifusion rate constant, kH, at pH 4.5 
is ~2.3-fold higher than at pH 5.1. Compared to a standard egg-adapted strain, X-31, 
the kH values of H10N8 are always ~2-fold higher than the kH values from influenza 
X-31. The kinetic data here suggests that after endosomal uptake, due to the lower pH 
of HA activation pH for JX346, it may release its genome later along the endosomal 
pathway than X-31, so the viral genomes may have a better chance to reach the host 
nucleus [104, 105, 178]. Additionally, at lower pHs, the hemifusion rate of H10N8 is 
higher than X-31, which may also indicate that more fusion activity occurs in late 
endosomes for H10N8 than for X-31, which may correlate overall to more infection. 
Looking at the N parameter from the fits, it appears that both H10N8 and X-31 in 
general require ~3 cooperating proteins over most of the physiological pH range. This 
result agrees that in general, three HA trimers are needed for fusion to take place 
[135]. 
 
4.3.5. Extent of fusion. The extent of fusion of H10N8 pseudotyped particles can 
provide an additional parameter for evaluating the pathogenic potential of H10N8. 
Using hemifusion data from the single particle tracking assay described previously, 
we calculated the extent of hemifusion for H10N8. The extent of hemifusion is 
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defined as the ratio, expressed in percentage, between the number of fused virions and 
the number of bound virions at t0 (right before pH is dropped). In figure 24, the extent 
of fusion of H10N8 is plotted at different initiation pHs. At pH 4, H10N8 has the 
highest extent of fusion at ~35%, and at pH 5.1 it reaches its lowest value at ~16%. 
The trends show that the extents of fusion decrease with increasing pH, which is 
similar to the trend of the number of nuclei in the syncytia (Fig. 21B). Comparison of 
the extent of fusion of H10N8 with the ones of X-31 and two other H3N2 strains 
(A/Brisbane/07/H3N2 (Brisbane) – clinical strain , and A/Udorn/72/H3N2 (Udorn) – 
another egg-adapted strain) characterized previously [170], shows that H10N8 has a 
fusion extent that is higher than the ones for X-31 and the Brisbane strains, but lower 
than the one for the Udorn strain [35].  
 
Figure 24. Extent of fusion for three H3N2 strains (Udorn, Brisbane and X-31) 
and H10N8 (JX346) over the range of examined pHs. The extent of fusion is 
defined as (number of fusion virions)/(number of bound virions at t0) × 100%. The 
data of Udorn, Brisbane, and X-31 were replotted from our previous publication [35].  
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4.3.6. H10 acid stability. Another parameter for evaluating pathogenicity of a 
potentially pandemic strain is the ability of HA to remain fusion competent in an 
acidic environment, also referred to here as its acid-dependent structural stability. 
This parameter can be obtained by examining the distribution of HA-mediated 
hemifusion events over time as a function of pH derived from the hemifusion kinetic 
data (Fig. 25A). From this data, the time of the last hemifusion event for each pH is 
plotted against the pH. For H10N8, the last hemifusion events occurs between 
~80-110 s over all initiating pHs tested, indicating that the acidification deactivates 
H10 beyond this time point. The advantage of SPT here is that because we can 
visually monitor each individual particle, we can obtain more precise information on 
how long HA can remain fusogenic in different acidic environments. Costello et al. 
previously demonstrated that the HA of the human clinical H3N2 strain, 
A/Brisbane/07/H3N2 (Brisbane), can remain stable relatively longer, in an 
acid-independent manner (~140 s) than common laboratory-adapted strains [35]. Here 
we note that the extent of fusion of H10N8 is higher than the H3N2 strain (Brisbane). 
However, when comparing Brisbane and JX346 to laboratory-adapted H3N2 strains, 
both are more acid-stable, but JX346 does not sustain as long in an acidic 
environment as the Brisbane strain before becoming inactivated. 
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Figure 25. Acid stability of H10. (A) Cumulative distribution of hemifusion events 
at pH 4, 4.5, 4.9 and 5.1 (from left to right) from t = 0 s to t = 30 s. (B) Time point at 
which the curves to the top reach 1.0 indicating when fusion activity ceases at each 
pH value. The values for X-31 and Brisbane are replotted from Costello et al. data 
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[35]. 
 
3.4. Discussion 
The objective of this work is to use individual virion fusion assays to characterize an 
emergent influenza strain’s fusion properties and gain more insight into its pandemic 
potential. Western blot analyses indicated that the rabbit anti-H10 antibody can bind 
to an epitope on HA1 on pseudotyped particles made from the JX346 coat protein 
sequences. H10 incorporation into particles was decreased in absence of N8 
co-expression, which suggests that H10 HA requires its matching NA for efficient 
incorporation into particles. Furthermore, cell-cell fusion assays indicate that H10 
fusion is pH-dependent and syncytia were first observed at pH 5.1. JX346 strain 
H10N8 pseudotyped particles were further examined for their fusion attributes at the 
single-particle level, which was necessary due to the unavailability of native virus 
particles.  
The HA fusion activation pH of influenza virus (JX346) was determined both by 
cell-cell fusion assays and SPT analyses. While cell-cell fusion assay allows 
determination of the pH threshold for initiating HA fusion, it does not provide other 
information regarding HA fusion attributes. SPT can provide a more comprehensive 
characterization. With SPT, we can determine the initiating pH threshold for 
HA-mediated fusion (HA fusion activation), the rate at which fusion occurs as a 
function of initiating pH (pH–dependent kinetics), the duration of HA activity in a 
given acidic environment (HA acid stability), and the extent of overall fusion at a 
given initiating pH. It is important to note that the highest fusion initiation pH does 
not always correlate with maximal fusion rate.  
The acid stability of HA is a factor that can be important in determining the successful 
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outcome of an infection because it impacts the timing of release of viral RNA within 
an infected cell [35]. Also, the acid stability promotes the survival of virus in a more 
acidic human airway before getting into the endosome, so the HA does not get 
deactivated before cellular uptake. Considering all the data from SPT and cell-cell 
fusion assays, it appears that H10N8 may have evolved towards better acid stability to 
overcome the naturally more acidic environments in potential new hosts, like the 
natural barrier of the human airway [42, 179]. Furthermore, H10 HA shows an 
increased rate of fusion as the initiating pH is decreased. Together these data indicate 
that the properties H10 of JX346 are conducive to shifting the tropism of this virus to 
human hosts. However, considering the findings that JX346 H10 binds more 
preferentially to α2,3 galactose-linked SA than α2,3 galactose-linked SA [180], and 
H10 can be cleaved by trypsin and weakly by matriptase[149], suggests JX346 is 
more an avian influenza virus than a human influenza virus.  In conclusion, we 
suggest that HA fusion properties, including pH of HA fusion activation, HA acid 
stability, and rates of fusion, might be several crucial factors important for assessing 
virus transmission ability. Hence, these attributes should be considered as part of the 
influenza risk assessment tool (IRAT). 
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CHAPTER 5 
CONCLUSIONS & OUTLOOK 
This thesis has presented several achievements for understanding influenza virus-host 
interaction at the single-particle level. The single particle tracking (SPT) technique 
used in this thesis offers new insights into the mechanism that influenza viruses use to 
enter cells and cause local and systemic infection. This work provides insight into the 
impact of influenza reassortment on virus entry and extends the application of SPT 
technique to further investigate an influenza antiviral drug. 
The importance of this thesis is that we developed new tools to study highly 
pathogenic viruses while minimizing safety concerns. Pseudoviruses have been 
utilized widely in the field to replace the native pathogenic viruses. However, there 
was no reported data to demonstrate that pseudoviruses mimic the native virus entry 
at the single-particle level. Hence, by applying the pseudovirus system, we first 
showed that pseudovirus particles mimicking a lab-adapted strain, influenza X-31, 
recapitulate the native, live virus fusion behavior. Next, we wanted to investigate the 
influenza reassortment process and we generated reassorted particles. We conducted 
SPT experiment on these influenza reassorted pseudoviruses and found that the 
reassortment impacted the virus hemifusion kinetics. We ultimately determined that 
the mismatching NAs slowed down the fusion kinetics by hampering the HA 
trafficking inside the HA/NA expressing cells. This work demonstrated that although 
influenza reassortment causes serious pandemic in human societies, the mutation is 
not always infectious because it might prevent the HA from becoming packaged on 
the virus membrane.  
After confirming that the pseudoviruses can serve as the best mimic for native 
pathogenic viruses, we further applied SPT techniques to an emerging influenza virus 
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(JX346). JX346 was initially characterized in a human case in 2013 in Jiangxi 
Province, China (strain A/Jiangxi-Donghu/346/2013(H10N8), or H10N8 (JX346)) 
[69]. So far, three human cases have been reported, two of which were fatal, 
suggesting that future cases of human infection with H10N8 may be associated with a 
high fatality rate [71]. In this study, we showed that the highest pH for HA fusion 
activation for JX346 is relatively low at pH 5.1, corroborating previous reports that 
lower activation pH is an adaptation detected in strains that jump to human hosts. 
Moreover, we showed that the rate of membrane hemifusion of JX346 is pH 
dependent, similar to what we observed for X-31, a lab-adapted H3N2 strain. 
However, in contrast to X-31, but similar to H3N2 human clinical strains, JX346 
strains remains fusion-competent longer in a low pH environment. Given these 
features, JX346 has entry properties that could promote transition to human hosts and 
underscores that fusion attributes should be included in the influenza risk assessment 
tool (IRAT). In the future, SPT can be a helpful tool for surveilling the emerging 
influenza viruses and evaluating their potential of causing pandemic in humans.  
Lastly, from ongoing work in collaboration with Prof. Hang at the Rockefeller 
University, we applied the SPT technique to investigate the impact of an interesting 
membrane protein, interferon-induced transmembrane proteins IFITM 3 on viral entry 
(appendix A). IFITMs have been shown to inhibit virus entry, but the actual cellular 
and biochemical mechanism of how they modulate the antiviral activities is still 
unclear. Hence, using SPT to study the IFITM3 inhibitory mechanism may benefit the 
field because it can easily distinguish whether IFITM3 affects viral binding, 
hemifusion or pore formation. Furthermore, SPT provides a purer system that only 
focuses on the impact of IFITM3 on virus entry.  
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APPENDIX A 
SINGLE PARTICLE TRACKING ASSAY OF ANTIVIRAL MEDICINE EFFECT 
ON INFLUENZA VIRUS MEMBRANE FUSION 
0. Acknowledgement 
This appendix is an ongoing work in collaboration with Prof. Hang at the Rockefeller 
University. In the thesis, I include part of the materials from Dr. Percher’s dissertation 
to facilitate reader’s understanding [181]. Emma Garst from the Rockefeller 
University, who mainly collaborates with us, provided all proteoliposome samples for 
making supported lipid bilayers in the SPT assay. 
1. Introduction 
Genetic and proteomic screens have found various candidate immune receptors, 
regulators and effectors [182, 183], however, the cellular and biochemical 
mechanisms of these host factors are most unclear. Among these factors. 
interferon-induced transmembrane proteins (IFITMs,) 1, 2, and 3 have been shown to 
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inhibit pathogen infection in vertebrates [184]. Particularly, IFITM3 attracts our 
attention because it was shown to mediate cellular resistance to influenza A virus 
(IAV) infection in mammalian cells[185]. As the IFITM family is the first ISG known 
to interfere with viral fusion and content entry, considerable interest has emerged in 
understanding their characterization and mechanism. 
IFITM3 restriction of viral infection occurs at the stage of viral fusion and content 
delivery[186]. Although it’s well know that AIV utilizes sialic acid as the receptor for 
binding and fusion, the mechanism of IFITM3’s antiviral activity is still unknown. An 
unbiased conjecture of possible mechanisms include (1) an indirect mechanism 
whereby IFITM3 recruits a yet unknown protein/cofactor responsible for the 
alternation of the fusion environment, either by changing membrane properties, or by 
altering the maturation pathway of the endosomal vesicle, (2) a direct mechanism in 
which IFITM3 alters the endosomal membrane’s biophysical properties such as 
membrane fluidity or curvature capacity,  (3) the maturation of the endosomal 
vesicle, directing the viral particle to an incompatible environment, or (4) IFITM3 
directly interacts with the viral particle, interfering with the completion of fusion to 
unveil the antiviral mechanism of IFITM3. 
Currently, there are two models for IFITM3’s antiviral behavior. It can  interfere 
with hemifusion or interfere with pore formation. In 2013, Amini-Bavil-Olyaee et al. 
proposed that IFITM3 interferes with viral entry by disrupting cholesterol export from 
the late endosome[187]. They found that IFITM3 inhibits vesicle associated 
membrane protein-A (VAP-A), which plays a role in the cholesterol export pathway 
mediated by NPC-2/1 and ORP family proteins[188]. As IFITM3 inhibits VAP-A 
protein, they hypothesized that it will cause an increase of cholesterol in late 
endosomes and this increase makes the endosomal membranes stiffer. A stiff 
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membrane will impede viral hemifusion until the virus particle is degraded in the 
lysosome. However, Desai et al.[189] proposed that instead of interfering the 
hemifusion step, IFITM3 interferes with the pore formation step. They performed 
virus-cell fusion assay to image a single virus in live cells. On the other hand, our 
collaborator, Professor Hang’s group at Rockefeller University, used bulk fusion 
assay to study the impact of IFITM3 on H1N1 (PR8) entry. They found that by 
reconstituting IFITM3 proteins into GD1a liposome, IFITM3 seems to be able to 
decrease the hemifusion between viruses and proteoliposomes. 
To further clarify the inhibitory mechanism of IFITM3 in influenza infection, I 
employed single particle tracking (SPT) techniques, which is a useful tool that can 
easily decouple viral binding, hemifusion, and pore formation, and quantify the data 
at a single-particle level. In this appendix, we compare the binding and hemifusion 
kinetics of influenza A H1N1 (PR8) to various proteoliposomes, including a negative 
protein control, VAMP, IFITM3, and the loss-of-function IFITM3 mutants. We also 
compare the SPT results with Professor Hang’s unpublished bulk fusion data. The 
results will be able to shed some light on the IFITM3 inhibitory mechanism against 
influenza A virus. 
2. Materials and Methods 
2.1. Induction and Enrichment of IFITM3 [181] 
The Sumo-IFITM3 construct was transformed into the BL-21 LOBSTR cell line[190] 
containing the RIL plasmid (BL21-CodonPlus-RIL strain, Agilent) for increased 
copies of tRNA argU (AGA, AGG), ileY (AUA), leuW (CUA). Single colonies were 
grown overnight in LB media containing kanomycin (50 µg / mL) and 
chloramphenicol (25 µg / mL). The following day, overnight cultures were diluted 
1:30 in 1 L LB with kanomycin, and incubated at 37 °C to an O.D. of 0.6 the culture 
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was then transferred to 18 °C, induced with 0.5 µM IPTG, and incubated overnight 
for 16 – 20 h. The following day, aliquots of 500 mL of cultures were spun down at 
4,000 g for 15 min, and the bacterial pellet were snap frozen in liquid nitrogen for 
future use. On the day of purification, a 500 mL bacterial pellet was thawed on ice, 
and resuspended in 40 mL Buffer A (25 mM HEPES, 100 mM KCl, pH 7) with 2% 
w/v Triton-X 100, and 1x protease inhibitor mixture (Roche). If the purified protein 
contained any cysteines, 1 mM β-mercaptoethanol (Sigma) was added. The 
resuspended pellet was incubated at room temperature (RT) with 10 mg lysozyme, 
then sonicated (Sonic Dismembrator Model 500, Fisher Scientific) for one minute 
(30% power, 1 second on, 1 second off). The sample was inverted several times to 
ensure mixture of lysate. Sonication was repeated twice more to ensure complete lysis. 
After sonication, the sample was diluted 2.5 fold in Buffer A without Triton-X 100 
(final volume 100 mL, 0.8% Triton-X 100), and spun down at 40,000 g for 45 min 
(Beckman Coulter Optima XL-100K Ultracentrifuge). 
During centrifugation, 12 mL of resuspended cobalt beads (‘Talon metal affinity resin’ 
Clontech) were washed once with water, and twice with Buffer A. Post spin, the 
supernatant was collected and the cobalt beads added for two hours with nutation at 4 
°C. The beads were then collected in an XK16/20 Column (Akta), and eluted using an 
AKTAFPLC chromatography system. It is during this stage that the detergent was 
switched from TritonX-100 to 1% octyl glucoside (Anatrace). Using a two pump 
protocol, the beads were treated stepwise with varying ratios of two different buffers: 
Buffer B (25 mM HEPES, 100 mM KCl, 1% octyl glucoside, pH 7), and Buffer 
B-imid, identical to Buffer B but containing 400 mM imidazole. If a construct with a 
cysteine was present, both buffers contained 1 mM neutralized TCEP (Thermo). BME 
contains a thiol, which interferes with the future step of coupling the palmitate. The 
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beads were washed with 20 mL buffer B, then 20 mL of 90% Buffer B, 10% Buffer 
B-imid. Finally, the protein was eluted with 20 mL Buffer B-imid, and collected in 
two mL fractions. After the elution, fractions corresponding with the peak of the 
protein were incubated overnight with nutation and ULP1 (1 mM TCEP was added if 
apoIFITM3 was being purified), and analyzed the following day by SDS-PAGE. 
After cleavage of the SUMO domain was confirmed, the appropriate fractions were 
collected and mixed, and 2 mL fractions were snap frozen in a dry-ice ethanol bath. 
Note: Reducing agents such as TCEP or DTT are necessary for ULP1 activity. If the 
sample did not require alkylation with maleimide-palmitate (i.e. apoIFITM3), then the 
SUMO domain was separated from the native IFITM3 by size exclusion 
chromatography (SEC) in Buffer B (10/300 GL, AKTA). In our hands, the SUMO 
domain consistently elutes after the IFITM3, making size exclusion a useful method 
to both remove background proteins as well as the enrichment tag.  
2.2. Generation of proteoliposome through the rapid dilution method. (Dr. 
Percher’s work) 
Modified from Weber et al. [191]. All chloroform solutions were stored in appropriate 
borosilicate glass with PTFE lined caps (VWR). Phosphatidylcholine and 
phosphatidylethanolamine suspended in chloroform were purchased from Avanti 
Lipids. 10 mg cholesterol (Sigma) was resuspended in 1 mL HPLC grade chloroform 
(Sigma), for a final concentration of 25.88 mM.  GD1a (Sigma) was resuspended in 
a 1:2 methanol:chloroform solution, for a final concentration of 0.544 mM (MW 
1882).   
For a final total concentration of 1 mM lipid (cholesterol included), 
appropriate volumes of each lipid were added to a 13 x 100 mm glass vial, and dried 
under a gentle argon stream (a clear reside is observable from the bottom of the vial). 
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The sample was then placed under vacuum for at least 2 hours. The dried lipid was 
resuspended in 1/4 the final total volume by adding Buffer A containing 1% OG, 
followed by horizontal shaking (gentle agitation can also be used). Higher 
resuspension concentrations will result in an opaque solution. The resuspended lipid 
was then aliquoted to other glass vials according to the number of conditions planned. 
After the addition of protein (the volume of protein + lipid cannot exceed 1/3 final 
volume), the lipid-protein solutions were left at RT for several minutes, Afterwards, 
the solution was rapidly diluted. by pressing the glass vial down with one hand on a 
table top vortex machine turned to high, and using the other hand to add  2-3x the 
volume of the solution, buffer A without detergent (depending on starting volume). 
This dilutes the OG below the CMC of 0.5% (final 0.25 – 0.3 %), driving the 
formation of liposomes.  
To dialyze out the remainder detergent, the entire liposome solution was added 
to pre-primed Slide-A-Lyzer MINI Dialysis wells (Thermo, 10k MWCO). Different 
sized wells were used depending on the volume of the solution (0.5 mL wells for 
4-500 µL volumes, 3 mL wells for 1-2 mL volumes). The wells were then shaken 
horizontally at RT for 1 hr, followed by a buffer exchange and dialysis with 
horizontal shaking for 6 hr at 4 °C. Finally, an additional buffer exchange was done, 
and incubated overnight at 4 °C with horizontal shaking. The next day, the samples 
were transferred to Eppendorf tubes with a pipette, and used for the described assays. 
Samples were kept for a maximum 1 week at 4 °C.  
2.3. Surface preparation 
Glass microscope coverslips (25 mm × 25 mm; No. 1.5) from VWR were cleaned in 
piranha solution (45 mL 50% hydrogen peroxide and 105 mL 70% sulfuric acid) for 
10 min, then rinsed 30 min with deionized water with a minimum resistance of 18.2 
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MΩ cm (Siemens Purelab Ultra water purification system). Glass slides were flushed 
by deionized water again and dried by a stream of ultra-pure nitrogen gas prior to 
plasma cleaning.  
2.4. Microfluidic device fabrication 
Microfluidic device fabrication procedure for hemifusion experiments was described 
in the previous chapters. 
5.2.5. Virus membrane labeling and purification 
Influenza A virus (A/Puerto R8/1934/H1N1)(PR8) was purchased from Charles River. 
5 µL PR8 was added into 250 µL PBS buffer, and 0.5 µL of 0.1 mg/mL octadecyl 
rhodamine B (R18) was added into the virus solution. The solution then was sonicated 
gently in a water bath for 55 minutes. The free R18, which did not insert into the viral 
membrane, was removed from labeled virus using a G-25 spin column for two 
minutes at 3000 rpm. The supernatant containing the purified viruses was diluted with 
750 µL PBS buffer before use. 
2.6. Single-virion hemifusion assay 
The procedure of performing single-virion hemifusion assay was described in the 
previous chapters. The only difference is the temperature was maintained at 32 °C 
during the assay. 
3. Result & discussion 
3.1. Using SPT to test the impact of IFITM3 on PR8 hemifusion kinetics 
When optimizing the technique for H1N1 (PR8), we found that it is not easy to obtain 
hemifusion events at room temperature (22 °C), but our control case, influenza H3N2 
(X-31) can fuse at room temperature under the same bilayer and environmental 
conditions. Moreover, Tsurudome et al. found that the function of fusion peptide of 
PR8 is affected by temperature, but the function of fusion peptide of X-31 is 
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temperature independent[192]. Hence, we characterized the hemifusion behavior of 
H1N1 (PR8) at pH 4.5 and 32 °C (fig. 28). For preliminary testing, we chose 1:5000 
and 1:20,000 protein to lipid molecule dilution because we want to understand the 
impact of protein concentration on the antiviral activity. We found that PR8 virus 
binding numbers are not significantly different when bound to GD1a liposomes with 
reconstituted IFITM3 or VAMP or when bound to GD1a control liposomes. However, 
we found that the presence of IFITM3 or VAMP drastically decreases the fusion 
extent of PR8 by 2/3 when compared to GD1a control liposomes. Furthermore, after 
plotting the hemifusion kinetics, it is shown that the presence of VAMP does not 
affect the rate of hemifusion, whereas the presence of IFITM3 proteoliposomes slows 
down the hemifusion rate at pH 4.5. To fully understand the IFITM3 inhibitory 
mechanism, we will need to obtain more hemifusion events to ensure the results are 
statistically significant and to test more acidic pH values because it may be possible 
that IFITM3 exhibits different function or activity at different pH values.  
 
Figure 28. Hemifusion kinetics of H1N1 (PR8) to various proteoliposomes with 
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GD1a receptor. 
 
The observation in SPT technique can explain the findings in bulk fusion done by Dr. 
Percher [181]. Moreover, SPT data suggests that the decrease of fusion extent from 
utilizing IFITM3 proteoliposomes may be because the hemifusion kinetics is impeded, 
when compared to using VAMP proteoliposomes.  
 
 
